Data / Research funding / Clinical Trials and Supportive Activities
Clinical Trials and Supportive Activities: 15,014 NIH awards ($33.3B) to 1,427 organizations
15,014 NIH awards ($33.3B) in the NIH spending category Clinical Trials and Supportive Activities, to 1,427 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
Get awards on Clinical Trials and Supportive ActivitiesWatch Clinical Trials and Supportive Activities
- Topic
- NIH spending category
Awards
The 500 largest of 15,014 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $472,070,715 | December 1, 2024 | November 30, 2025 | CURRIER, JUDITH S. | reporter.nih.gov |
| NIAID HIV and Other Infectious Diseases Clinical Research Support Services (CRSS) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $417,904,831 | August 15, 2023 | August 14, 2024 | STROKES, BAMBRA | reporter.nih.gov |
| HIV Vaccines Clinical Trials Network Leadership and Operations Center | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $244,071,463 | June 29, 2006 | November 30, 2027 | COREY, LAWRENCE | reporter.nih.gov |
| HIV Prevention Trials Network Leadership and Operations Center | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $213,590,410 | June 1, 2006 | November 30, 2027 | COHEN, MYRON SCOTT | reporter.nih.gov |
| Immune Tolerance Network | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $203,912,588 | February 1, 2014 | January 31, 2028 | BUCKNER, JANE HOYT | reporter.nih.gov |
| HIV and Other Infectious Diseases Clinical Research Support Services (CRSS) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $198,645,463 | August 15, 2025 | August 14, 2026 | STOKES, BAMBRA | reporter.nih.gov |
| HIV Vaccine Trials Network Laboratory Center | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $177,480,054 | June 29, 2006 | November 30, 2027 | MCELRATH, MARGARET JULIANA | reporter.nih.gov |
| SDMC: HIV Vaccine Trials Network | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $156,744,802 | June 29, 2006 | November 30, 2027 | GILBERT, PETER B. | reporter.nih.gov |
| CoVPN LOC Cross-Protocol Infrastructure Supplement for GY15 and GY16 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $156,469,927 | March 30, 2022 | March 31, 2022 | COREY, LAWRENCE | reporter.nih.gov |
| Consortium for HIV/AIDS Vaccine Development | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $145,502,241 | July 1, 2019 | June 30, 2026 | BURTON, DENNIS R. | reporter.nih.gov |
| Induction of protective antibodies for HIV vaccine development | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $143,048,158 | July 15, 2019 | June 30, 2026 | HAYNES, BARTON F. | reporter.nih.gov |
| COG NCTN Year 12 BIQSFP Progress Report | NIH | National Cancer Institute | 2021 to 2025 | $141,250,012 | April 11, 2014 | February 28, 2026 | HAWKINS, DOUGLAS S. | reporter.nih.gov |
| Consortium for Advancing Management and Prevention of Cancer in People with HIV | NIH | National Cancer Institute | 2021 to 2025 | $106,635,299 | August 29, 2006 | August 31, 2030 | SPARANO, JOSEPH A. | reporter.nih.gov |
| Data Coordinating Center for Type 1 Diabetes TrialNet | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $99,686,705 | September 30, 2015 | May 31, 2030 | KRISCHER, JEFFREY P | reporter.nih.gov |
| ECOG-ACRIN NCORP Research Base | NIH | National Cancer Institute | 2021 to 2025 | $95,697,835 | August 1, 2014 | July 31, 2026 | WAGNER, LYNNE I. | reporter.nih.gov |
| Alzheimer's Disease Neuroimaging Initiative (ADNI4) | NIH | National Institute on Aging | 2022 to 2025 | $95,332,786 | September 30, 2004 | July 31, 2028 | WEINER, MICHAEL W | reporter.nih.gov |
| CANCER THERAPY EVALUATION PROGRAM INFORMATICS & COMPUTER SUPPORT | NIH | National Cancer Institute | 2021 to 2025 | $86,933,457 | July 1, 2022 | June 30, 2026 | RAJU, SUDHIR | reporter.nih.gov |
| Statistical and Data Management Center (SDMC), Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (ACTG) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $84,840,845 | June 29, 2006 | November 30, 2027 | HUGHES, MICHAEL DAVID | reporter.nih.gov |
| DIAN-TU Primary Prevention Trial | NIH | National Institute on Aging | 2021 to 2025 | $79,373,454 | September 15, 2018 | May 31, 2026 | MCDADE, ERIC MARTIN | reporter.nih.gov |
| Antibacterial Resistance Leadership Group (ARLG) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $78,031,274 | June 1, 2013 | November 30, 2026 | FOWLER, VANCE G. | reporter.nih.gov |
| IMPAACT Leadership Group | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $77,468,129 | December 1, 2024 | November 30, 2027 | NACHMAN, SHARON A | reporter.nih.gov |
| TASK ORDER 4A SITE STUDY SETUP: CTSU IDIQ | NIH | National Cancer Institute | 2022 to 2025 | $77,467,748 | August 1, 2022 | July 31, 2026 | PATRICHUK, LUCILLE | reporter.nih.gov |
| HPTN SDMC: HPTN 096 Getting to Zero among Highest HIV Incidence (HHI) Men who have Sex with Men (MSM) in the American South: Testing an Integrated Strategy | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $74,729,762 | June 29, 2006 | November 30, 2027 | DONNELL, DEBORAH J | reporter.nih.gov |
| Clinical and Translational Science Award | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $73,235,012 | August 18, 2015 | May 19, 2026 | BREDELLA, MIRIAM ANTOINETTE | reporter.nih.gov |
| COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: UNIVERSAL INFLUENZA VACCINE RESEARCH | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $72,825,966 | September 10, 2019 | September 24, 2026 | KRAMMER, FLORIAN | reporter.nih.gov |
| Technology to Empower Changes in Health (TECH) Network Participant Technologies Center | NIH | Office of the Director, National Institutes of Health | 2021 to 2022 | $71,400,578 | July 6, 2016 | June 30, 2023 | TOPOL, ERIC JEFFREY | reporter.nih.gov |
| NIAID CLINICAL SITE MONITORING | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $68,539,045 | February 1, 2023 | January 31, 2024 | SMITH, KIMBERLY | reporter.nih.gov |
| Alzheimer's Disease and Alzheimer's Disease Related Dementias in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Outcomes Study AD/ADRD Project | NIH | National Institute on Aging | 2022 to 2025 | $66,521,567 | September 1, 2022 | August 31, 2027 | LUCHSINGER, JOSE ALEJANDRO | reporter.nih.gov |
| NIDA Clinical Trials Network: New York Node (CTN-0139, CTN-0155, CTN-Biostats) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $66,452,521 | March 1, 2025 | February 29, 2032 | MCNEELY, JENNIFER | reporter.nih.gov |
| NCI Early Career Cancer Clinical Investigator Award | NIH | National Cancer Institute | 2021 to 2025 | $65,560,307 | March 10, 1997 | November 30, 2026 | EBERT, BENJAMIN LEVINE | reporter.nih.gov |
| Alliance for Clinical Trials in Oncology Operations Center - GY11 BIQSFP Funded Extension | NIH | National Cancer Institute | 2021 to 2025 | $65,300,792 | April 17, 2014 | February 28, 2026 | PIANTADOSI, STEVEN | reporter.nih.gov |
| Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $63,155,364 | December 5, 2019 | November 30, 2026 | STEPHENS, DAVID S | reporter.nih.gov |
| ProNET: Psychosis-Risk Outcomes Network | NIH | National Institute of Mental Health | 2021 to 2025 | $61,984,741 | September 8, 2020 | May 31, 2026 | WOODS, SCOTT W | reporter.nih.gov |
| The Alzheimer's Disease Tau Platform Clinical Trial | NIH | National Institute on Aging | 2023 to 2024 | $60,700,604 | September 21, 2023 | August 31, 2028 | BOXER, ADAM L. | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $59,316,664 | August 28, 1996 | June 30, 2026 | DRAETTA, GIULIO FRANCESCO | reporter.nih.gov |
| SDMC - IMPAACT Leadership Group | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $59,233,299 | June 29, 2006 | November 30, 2027 | SHAPIRO, DAVID ERIC | reporter.nih.gov |
| CTN New England Consortium Node | NIH | National Institute on Drug Abuse | 2021 to 2025 | $58,365,118 | March 1, 2025 | February 29, 2032 | D'ONOFRIO, GAIL | reporter.nih.gov |
| CoVPN 5001 - A prospective study of acute immune responses to SARS-CoV-2 infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $57,987,348 | March 21, 2022 | March 31, 2022 | GILBERT, PETER B. | reporter.nih.gov |
| GY11 BIQSFP Supplement Request | NIH | National Cancer Institute | 2021 to 2025 | $57,110,172 | March 17, 2025 | February 28, 2026 | BLANKE, CHARLES D. | reporter.nih.gov |
| AIDS Clinical Trial Group Laboratory Center | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $56,714,107 | January 1, 2014 | November 30, 2027 | ALDROVANDI, GRACE M | reporter.nih.gov |
| NRG Oncology NCORP Research Base-BIQSFP | NIH | National Cancer Institute | 2021 to 2025 | $54,340,726 | July 11, 2025 | July 31, 2026 | BRUNER, DEBORAH WATKINS | reporter.nih.gov |
| HVTN 405/HPTN 1901 (CoVPN) Characterizing SARS-CoV-2-specific Immunity in Convalescent Individuals: LC 3 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $54,331,950 | March 18, 2022 | March 31, 2022 | MCELRATH, MARGARET JULIANA | reporter.nih.gov |
| Yale Clinical and Translational Science Award | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $53,543,083 | July 1, 2016 | March 31, 2027 | SMITH, BRIAN RICHARD | reporter.nih.gov |
| University of Pittsburgh Clinical and Translational Science Institute | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $52,585,662 | July 12, 2016 | July 31, 2026 | REIS, STEVEN E | reporter.nih.gov |
| Vanderbilt Institute for Clinical and Translational Research (VICTR) | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $52,517,120 | June 1, 2017 | February 28, 2027 | SELF, WESLEY H | reporter.nih.gov |
| Collaborative Influenza Vaccine Innovation Centers (CIVICs) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $52,452,735 | September 10, 2019 | September 9, 2026 | MOODY, TONY | reporter.nih.gov |
| DAIDS Quality Assurance, Quality Control and Inspection Readiness Support Services | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $51,529,857 | April 17, 2025 | April 16, 2026 | reporter.nih.gov | |
| Clinical and Translational Science Award | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $51,389,849 | August 1, 2022 | May 31, 2027 | REILLY, MUREDACH P | reporter.nih.gov |
| Access for All in ALS (ALL ALS) West Clinical Coordinating Center | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $51,203,440 | September 25, 2023 | June 30, 2027 | BOWSER, ROBERT P | reporter.nih.gov |
| Alliance NCORP Research Base | NIH | National Cancer Institute | 2021 to 2025 | $50,260,118 | August 1, 2014 | July 31, 2026 | PASKETT, ELECTRA D. | reporter.nih.gov |
| DIAN-TU: Tau Next Generation Prevention Trial | NIH | National Institute on Aging | 2021 to 2025 | $49,839,335 | September 15, 2020 | May 31, 2027 | BATEMAN, RANDALL J | reporter.nih.gov |
| Washington University Institute of Clinical and Translational Sciences | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $49,526,150 | June 19, 2017 | February 28, 2027 | POWDERLY, WILLIAM G. | reporter.nih.gov |
| Abramson Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $48,027,008 | January 15, 1997 | May 31, 2026 | VONDERHEIDE, ROBERT H. | reporter.nih.gov |
| Georgia Clinical & Translational Science Alliance (Georgia CTSA) | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $47,579,618 | September 22, 2017 | July 31, 2027 | TAYLOR, WILLIAM ROBERT | reporter.nih.gov |
| SUPPORT SERVICES OF THE HIV AIDS CLINICAL TRIAL NETWORKS | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $45,166,816 | November 30, 2022 | November 29, 2025 | DRIVER, BARBARA | reporter.nih.gov |
| Clinical and Translational Science Center | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $44,995,547 | September 5, 2017 | June 30, 2027 | IMPERATO-MCGINLEY, JULIANNE L | reporter.nih.gov |
| Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $44,959,734 | August 13, 2025 | November 30, 2026 | KOTLOFF, KAREN L. | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2022 to 2025 | $44,496,290 | January 1, 1997 | December 31, 2029 | LYNCH, THOMAS JAMES | reporter.nih.gov |
| NIDA Clinical Trials Network: Big South/West Node (CTN-0132 and CTN-0139) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $43,417,361 | March 1, 2025 | February 28, 2032 | TRIVEDI, MADHUKAR H. | reporter.nih.gov |
| DRCR Retina Network | NIH | National Eye Institute | 2021 to 2025 | $43,226,123 | September 30, 2002 | December 31, 2028 | GLASSMAN, ADAM R | reporter.nih.gov |
| Clinical and Translational Science Institute | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $42,377,367 | July 18, 2016 | June 30, 2026 | JACOBY, VANESSA | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $41,720,565 | June 1, 1997 | November 30, 2025 | FERRIS, ROBERT L. | reporter.nih.gov |
| Regional Oncology Research Center | NIH | National Cancer Institute | 2021 to 2025 | $40,980,320 | May 7, 1997 | May 31, 2027 | NELSON, WILLIAM GEORGE | reporter.nih.gov |
| LC: HIV PREVENTION TRIALS NETWORK | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $40,489,166 | June 1, 2006 | November 30, 2027 | ESHLEMAN, SUSAN H | reporter.nih.gov |
| Randomized Double Blind, Placebo Controlled, Parallel Group Trial to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease over 18 Months | NIH | National Institute on Aging | 2021 to 2025 | $39,702,286 | June 1, 2020 | May 31, 2027 | CAGGIANO, ANTHONY O | reporter.nih.gov |
| Southern California Clinical and Translational Science Institute | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $39,421,921 | July 1, 2016 | March 31, 2027 | BUCHANAN, THOMAS A | reporter.nih.gov |
| UT Southwestern Center for Translational Medicine | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $39,349,638 | May 26, 2021 | April 30, 2027 | TOTO, ROBERT DANIEL | reporter.nih.gov |
| Network for Cardiothoracic Surgical Investigations in Cardiovascular Medicine | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $39,139,386 | July 1, 2007 | February 28, 2027 | GELIJNS, ANNE CHRISTINE | reporter.nih.gov |
| University of Arizona-Banner Health All of Us Research Program | NIH | Office of the Director, National Institutes of Health | 2021 to 2023 | $38,867,875 | April 1, 2018 | August 31, 2024 | MORENO, FRANCISCO A | reporter.nih.gov |
| The Institute for Translational Medicine | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $38,399,460 | September 6, 2017 | June 30, 2027 | MELTZER, DAVID O | reporter.nih.gov |
| Cognitive training to reduce incidence of cognitive impairment in older adults | NIH | National Institute on Aging | 2021 to 2024 | $37,326,564 | February 1, 2021 | January 31, 2027 | O'BRIEN, JENNIFER LEE | reporter.nih.gov |
| UC San Diego Clinical and Translational Research Institute | NIH | National Center for Advancing Translational Sciences | 2021 to 2024 | $37,309,294 | August 13, 2015 | April 30, 2026 | FIRESTEIN, GARY S | reporter.nih.gov |
| Conduits: Mount Sinai Health System Translational Science Hub | NIH | National Center for Advancing Translational Sciences | 2022 to 2025 | $37,137,629 | July 10, 2022 | June 30, 2027 | WRIGHT, ROSALIND J | reporter.nih.gov |
| THE PURPOSE OF THIS MODIFICATION IS TO DE-OBLIGATE NHLBI FUNDING FROM THE WOMEN'S HEALTH INITIATIVE (WHI) - CLINICAL COORDINATING CENTER (CCC). | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $36,880,325 | February 1, 2021 | January 31, 2026 | ANDERSON, GARNET L. | reporter.nih.gov |
| Vanderbilt Vaccine and Treatment Evaluation Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $36,564,580 | December 11, 2019 | November 30, 2026 | CREECH, CLARENCE BUDDY | reporter.nih.gov |
| Blood and Marrow Transplant Clinical Trials Network DCC- The Medical College of Wisconsin, Inc. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $36,418,175 | September 15, 2017 | August 31, 2031 | HAMADANI, MEHDI HUSSAIN | reporter.nih.gov |
| Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study | NIH | National Institute on Aging | 2021 to 2024 | $36,190,244 | August 15, 2020 | May 31, 2025 | ABUSHAKRA, SUSAN | reporter.nih.gov |
| Kentucky CAN HEAL (Communities and Networks Helping End Addiction Long-term) | NIH | National Institute on Drug Abuse | 2021 to 2022 | $36,092,167 | April 17, 2019 | March 31, 2025 | WALSH, SHARON L. | reporter.nih.gov |
| Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Scientific Leadership Center | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $36,023,354 | January 25, 2023 | January 14, 2030 | HIGHTOW-WEIDMAN, LISA B | reporter.nih.gov |
| Mayo Clinic Center for Clinical and Translational Science (CCaTS) | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $35,528,345 | September 18, 2017 | June 30, 2027 | GAROVIC, VESNA D | reporter.nih.gov |
| NICHD Maternal-Fetal Medicine Units (MFMU) Network: Data CoordinatingCenter | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $35,207,419 | April 15, 1998 | March 31, 2030 | CLIFTON, REBECCA GERSNOVIEZ | reporter.nih.gov |
| Immune Mechanisms of Protection Against Mycobacterium Tuberculosis Center (IMPAC-TB) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $35,184,139 | August 1, 2021 | July 31, 2026 | COLER, RHEA | reporter.nih.gov |
| Epidemiology of Diabetes Interventions and Complications (EDIC) Study | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $35,015,476 | September 22, 2011 | June 30, 2027 | GUBITOSI-KLUG, ROSE A | reporter.nih.gov |
| Combination anti-amyloid therapy for preclinical Alzheimer's disease | NIH | National Institute on Aging | 2021 to 2024 | $34,903,050 | September 30, 2018 | May 31, 2025 | AISEN, PAUL S. | reporter.nih.gov |
| Childhood Asthma in Urban Settings Clinical Research Network - Leadership Center | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $34,858,092 | April 12, 2021 | March 31, 2028 | JACKSON, DANIEL J | reporter.nih.gov |
| SWOG NCORP Research Base | NIH | National Cancer Institute | 2021 to 2025 | $34,321,697 | August 1, 2014 | July 31, 2026 | BLANKE, CHARLES D. | reporter.nih.gov |
| University of Southern California Norris Comprehensive Cancer Center Support Grant (CCSG) | NIH | National Cancer Institute | 2021 to 2025 | $34,050,628 | December 1, 1996 | November 30, 2026 | LERMAN, CARYN | reporter.nih.gov |
| Tufts Clinical and Translational Science Institute | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $34,034,065 | May 1, 2023 | April 30, 2030 | SELKER, HARRY P. | reporter.nih.gov |
| Pediatric Eye Disease Investigator Group Coordinating Center | NIH | National Eye Institute | 2021 to 2025 | $33,066,572 | May 1, 1997 | December 31, 2028 | KRAKER, RAYMOND | reporter.nih.gov |
| Intermediate-Size Expanded Access Trial of Autologous Hybrid TREG/Th2 Cell Therapy (RAPA-501) of Amyotrophic Lateral Sclerosis | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $33,014,143 | September 25, 2023 | April 30, 2027 | BERRY, JAMES DALE | reporter.nih.gov |
| CHASE: An Innovative County-Level Public Health Response to the Opioid Epidemic in New York State | NIH | National Institute on Drug Abuse | 2021 to 2023 | $32,731,263 | September 15, 2023 | March 31, 2024 | EL-BASSEL, NABILA | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $32,609,322 | August 2, 2001 | June 30, 2027 | EBERLEIN, TIMOTHY J. | reporter.nih.gov |
| The Robert H. Lurie Comprehensive Cancer Center | NIH | National Cancer Institute | 2021 to 2025 | $32,389,955 | August 1, 1997 | July 31, 2030 | PLATANIAS, LEONIDAS C. | reporter.nih.gov |
| Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $32,243,461 | September 22, 2022 | October 9, 2029 | MEGAZZINI, KAREN | reporter.nih.gov |
| West Virginia Clinical and Translational Science Institute: A Statewide Organization Building Research Excellence and Engaging Communities to Improve Health | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $31,832,071 | August 15, 2012 | June 30, 2027 | HODDER, SALLY LYNN | reporter.nih.gov |
| Early Onset AD Consortium - the LEAD Study (LEADS) | NIH | National Institute on Aging | 2021 to 2023 | $31,594,379 | September 30, 2018 | May 31, 2025 | APOSTOLOVA, LIANA G | reporter.nih.gov |
| ProCAN: Psychosis Risk Outcomes Compound Assessment Network | NIH | National Institute of Mental Health | 2024 to 2025 | $31,583,752 | June 14, 2024 | May 31, 2029 | WOODS, SCOTT W | reporter.nih.gov |
| Children's Oncology Group | NIH | National Cancer Institute | 2023 to 2025 | $31,354,180 | March 1, 2023 | February 28, 2026 | ALONZO, TODD A | reporter.nih.gov |
| Data Coordinating and Operations Center for the ECHO IDeA States Pediatric Clinical Trials Network | NIH | Office of the Director, National Institutes of Health | 2021 to 2024 | $31,232,152 | September 23, 2016 | August 31, 2025 | OUNPRASEUTH, SONGTHIP T. | reporter.nih.gov |
| IPP - DRUG DEVELOPMENT SUPPORT FOR CTEP | NIH | National Cancer Institute | 2022 to 2025 | $31,120,905 | July 1, 2022 | June 30, 2026 | MILLER, LAUREN | reporter.nih.gov |
| Phase II randomized controlled trial of benfotiamine in early Alzheimer's Disease | NIH | National Institute on Aging | 2022 to 2025 | $30,295,384 | July 15, 2022 | June 30, 2028 | GIBSON, GARY E | reporter.nih.gov |
| The Progressive Supranuclear Palsy Clinical Trial Platform (PTP) | NIH | National Institute on Aging | 2024 to 2025 | $30,281,212 | August 15, 2024 | July 31, 2029 | BOXER, ADAM L. | reporter.nih.gov |
| Michigan Institute for Clinical and Health Research (MICHR) | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $30,048,018 | March 15, 2023 | February 28, 2030 | LUMENG, JULIE C | reporter.nih.gov |
| MassHEAL - Reducing overdose deaths by 40% (2019-2023) | NIH | National Institute on Drug Abuse | 2021 to 2023 | $29,970,213 | September 15, 2023 | March 31, 2024 | SAMET, JEFFREY H. | reporter.nih.gov |
| URCC NCORP Research Base | NIH | National Cancer Institute | 2021 to 2025 | $29,808,213 | June 1, 2025 | July 31, 2026 | MUSTIAN, KAREN M. | reporter.nih.gov |
| Center for Clinical and Translational Sciences (CCTS) | NIH | National Center for Advancing Translational Sciences | 2021 to 2023 | $29,767,611 | July 24, 2019 | August 31, 2024 | MCPHERSON, DAVID D | reporter.nih.gov |
| Neonatal Research Network Data Coordinating Center (DCC) 2023-2028 | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $29,678,342 | September 1, 2025 | March 31, 2026 | DAS, ABHIK | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $29,642,385 | September 12, 1997 | November 30, 2025 | RATHMELL, WENDY KIMRYN | reporter.nih.gov |
| A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study to Evaluate the Safety and Efficacy of CT1812 in Subjects with Dementia with Lewy Bodies | NIH | National Institute on Aging | 2021 to 2023 | $29,498,064 | May 15, 2021 | April 30, 2025 | CAGGIANO, ANTHONY O | reporter.nih.gov |
| FOLLOW-UP AND EXTENDED FOLLOW-UP OF PARTICIPANTS | NIH | National Cancer Institute | 2021 to 2025 | $29,487,084 | April 6, 2018 | September 15, 2026 | PORRAS, CAROLINA | reporter.nih.gov |
| Comprehensive Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $29,187,201 | March 28, 1997 | March 31, 2027 | SLECKMAN, BARRY P | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $28,807,695 | December 1, 1996 | March 31, 2030 | TEITELL, MICHAEL A | reporter.nih.gov |
| Allopregnanolone as Regenerative Therapeutic for Alzheimer's: Phase 2 Clinical Trial | NIH | National Institute on Aging | 2021 to 2025 | $28,784,116 | August 15, 2019 | April 30, 2027 | BRINTON, ROBERTA EILEEN | reporter.nih.gov |
| The Harvard Clinical and Translational Science Center | NIH | National Center for Advancing Translational Sciences | 2021 to 2022 | $28,733,176 | May 1, 2018 | June 15, 2023 | NADLER, LEE MARSHALL | reporter.nih.gov |
| North Carolina Translational and Clinical Sciences Institute (NC TraCS) | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $28,498,535 | April 28, 2023 | March 31, 2030 | SHAHEEN, NICHOLAS J | reporter.nih.gov |
| RhoFED CDSMC | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $28,374,518 | May 8, 2023 | April 30, 2028 | SCHMIDT, PETER N. | reporter.nih.gov |
| RhoFED AA-SCCC | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $28,163,551 | May 5, 2023 | April 30, 2028 | DAVID, GLORIA | reporter.nih.gov |
| Johns Hopkins Institute for Clinical and Translational Research | NIH | National Center for Advancing Translational Sciences | 2021 to 2023 | $28,163,371 | May 31, 2019 | July 14, 2024 | FORD, DANIEL ERNEST | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $28,048,179 | July 4, 1997 | June 30, 2030 | RUSTGI, ANIL K | reporter.nih.gov |
| An Intermediate-Size Expanded Access Protocol for Amyotrophic Lateral Sclerosis with Pridopidine | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $27,895,551 | September 25, 2023 | August 31, 2027 | PAGANONI, SABRINA | reporter.nih.gov |
| Southern California Center for Chronic Health Disparities in Latino Children and Families. | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $27,816,472 | September 24, 2021 | June 30, 2027 | GORAN, MICHAEL ISAAC | reporter.nih.gov |
| Deep South Center to Reduce Disparities in Chronic Diseases | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $27,671,310 | September 24, 2021 | June 30, 2027 | CHERRINGTON, ANDREA L | reporter.nih.gov |
| Children's Oncology Group NCI Community Oncology Research Program (NCORP) Research Base grant | NIH | National Cancer Institute | 2021 to 2025 | $27,607,459 | June 1, 2025 | July 31, 2026 | ROTH, MICHAEL E. | reporter.nih.gov |
| Childhood Cancer Survivorship Study | NIH | National Cancer Institute | 2021 to 2025 | $27,522,831 | July 20, 1993 | November 30, 2026 | ARMSTRONG, GREGORY | reporter.nih.gov |
| ATOPIC DERMATITIS RESEARCH NETWORK LEADERSHIP CENTER | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $27,224,161 | April 9, 2020 | March 31, 2027 | LEUNG, DONALD YM | reporter.nih.gov |
| Data Management and Coordinating Center: Rare Diseases Clinical Research Network | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $26,933,474 | August 5, 2019 | June 30, 2030 | MACALUSO, MAURIZIO | reporter.nih.gov |
| PPDs Application for the Transplantation Statistical and Clinical Coordinating Center (T-SCCC) (U01 Clinical Trial Not Allowed) | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $26,732,375 | June 12, 2023 | April 30, 2028 | SEVER, MICHELLE LYNN | reporter.nih.gov |
| Physical Rehabilitation for Older Patients with Acute HFpEF-The REHAB-HFpEF Trial | NIH | National Institute on Aging | 2022 to 2025 | $26,596,811 | August 15, 2022 | July 31, 2028 | KITZMAN, DALANE W | reporter.nih.gov |
| Comparison of Anti-coagulation and anti-Platelet Therapies for Intracranial Vascular Atherostenosis | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $26,536,563 | September 1, 2021 | May 31, 2028 | HOH, BRIAN LIM | reporter.nih.gov |
| A non-viral CRISPR-mediated genome editing delivery platform as a potential therapy for neurogenetic diseases | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $26,526,303 | September 20, 2023 | July 31, 2027 | JIANG, YONG-HUI | reporter.nih.gov |
| Center for Clinical and Translational Science | NIH | National Center for Advancing Translational Sciences | 2021 to 2023 | $26,363,939 | May 6, 2019 | April 30, 2024 | KIMBERLY, ROBERT P. | reporter.nih.gov |
| The Florida Node Alliance of the National Drug Abuse Clinical Trials Network (CTN-121) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $26,301,696 | March 1, 2025 | February 29, 2028 | SZAPOCZNIK, JOSE | reporter.nih.gov |
| API A4 Alzheimer's Prevention Trial | NIH | National Institute on Aging | 2021 to 2025 | $26,251,396 | September 1, 2018 | November 30, 2025 | REIMAN, ERIC MICHAEL | reporter.nih.gov |
| New Horizons in the Prevention and Treatment of Food Allergy | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $25,961,502 | April 4, 2024 | February 28, 2031 | WOOD, ROBERT A | reporter.nih.gov |
| Optimizing HEALing in Ohio Communities (OHiO)-Health Equity Supplement | NIH | National Institute on Drug Abuse | 2021 to 2023 | $25,859,414 | September 15, 2023 | March 31, 2024 | FREISTHLER, BRIDGET J | reporter.nih.gov |
| Data Coordinating Center (DCC) for the Neonatal Opioid Withdrawal Syndrome Pharmacological Treatments Comparative Effectiveness Trial (NOWS PhaCET) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $25,628,714 | September 20, 2021 | August 31, 2027 | DAS, ABHIK | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $25,514,923 | May 9, 1997 | April 30, 2027 | ULRICH, CORNELIA M | reporter.nih.gov |
| Colorado Clinical and Transational Sciences Institute | NIH | National Center for Advancing Translational Sciences | 2021 to 2022 | $25,109,323 | May 1, 2018 | April 30, 2024 | SOKOL, RONALD J. | reporter.nih.gov |
| Michigan-Pittsburgh-Wyss Regenerative Medicine Resource Center: Advancing Dental, Oral, and Craniofacial Regeneration to Clinical Trial Initiation | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $24,937,885 | May 1, 2020 | April 30, 2026 | KOHN, DAVID H. | reporter.nih.gov |
| Center for Chronic Disease Reduction and Equity Promotion Across Minnesota (C2DREAM) | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $24,809,662 | September 24, 2021 | December 31, 2026 | ALLEN, MICHELE L | reporter.nih.gov |
| US POINTER Neuroimaging Ancillary Study | NIH | National Institute on Aging | 2021 to 2025 | $24,762,483 | August 1, 2019 | March 31, 2027 | LANDAU, SUSAN M | reporter.nih.gov |
| University of North Carolina Global HIV Prevention and Treatment Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $24,477,809 | February 1, 2007 | November 30, 2027 | ERON, JOSEPH J | reporter.nih.gov |
| Nutrition for Precision Health, powered by the All of Us Research Program: Research Coordinating Center | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $24,418,322 | July 1, 2025 | November 30, 2025 | GANTZ, MARIE G | reporter.nih.gov |
| Chicago Chronic Conditions Engagement Network | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $24,257,718 | September 24, 2021 | June 30, 2027 | HUANG, ELBERT S. | reporter.nih.gov |
| Metformin in Alzheimer's dementia Prevention (MAP) | NIH | National Institute on Aging | 2021 to 2025 | $24,224,790 | August 15, 2019 | April 30, 2027 | LUCHSINGER, JOSE ALEJANDRO | reporter.nih.gov |
| Advance Clinical and Translational Research (Advance-CTR) | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $24,223,536 | July 1, 2016 | July 31, 2026 | ROUNDS, SHARON IRENE SMITH | reporter.nih.gov |
| The Mid-Atlantic Center for Cardiometabolic Health (MACCH) | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $24,163,298 | September 24, 2021 | June 30, 2027 | COOPER, LISA A | reporter.nih.gov |
| Clinical and Translational Science Collaborative of Northern Ohio, Catalyzing Linkages for Everyone's Health (CLE Health) | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $24,022,255 | August 2, 2023 | June 30, 2030 | MCCOMSEY, GRACE A | reporter.nih.gov |
| All of Us Research Program Trans-America Consortium of the HCSRN | NIH | Office of the Director, National Institutes of Health | 2023 to 2024 | $23,933,034 | September 1, 2023 | August 31, 2025 | PELTZ, CATHRYN | reporter.nih.gov |
| Center to Improve Chronic disease Outcomes through Multi-level and Multi-generational approaches Unifying Novel Interventions and Training for health EquitY (The COMMUNITY Center) | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $23,922,504 | September 24, 2021 | June 30, 2027 | TERRY, MARY BETH | reporter.nih.gov |
| Wake Forest NCORP Research Base | NIH | National Cancer Institute | 2021 to 2025 | $23,707,562 | August 1, 2014 | July 31, 2026 | LESSER, GLENN J | reporter.nih.gov |
| SDMC: HIV Prevention Trials Network | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $23,565,144 | June 29, 2006 | March 31, 2022 | DONNELL, DEBORAH J | reporter.nih.gov |
| Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Open-Label Extension Study | NIH | National Institute on Aging | 2021 to 2024 | $23,438,396 | May 15, 2019 | December 31, 2025 | SPERLING, REISA A. | reporter.nih.gov |
| University of Minnesota Clinical and Translational Science Institute (UMN CTSI) | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $23,126,699 | September 18, 2023 | July 31, 2030 | BLAZAR, BRUCE R | reporter.nih.gov |
| Nevada IDeA Networks of Biomedical Research Excellence (INBRE) | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $23,116,909 | September 1, 2001 | March 31, 2027 | BAKER, JONATHAN E. | reporter.nih.gov |
| Colorado Clinical and Translational Sciences Institute (CCTSI) | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $23,057,922 | September 15, 2023 | July 31, 2030 | SOKOL, RONALD J. | reporter.nih.gov |
| Vaccine and Treatment Evaluation Units | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $22,981,366 | December 11, 2019 | November 30, 2026 | ROUPHAEL, NADINE GEORGES | reporter.nih.gov |
| CCSG - Administrative Supplement - ECIA | NIH | National Cancer Institute | 2021 to 2025 | $22,920,176 | September 1, 1997 | March 31, 2029 | ODUNSI, KUNLE | reporter.nih.gov |
| Great Plains IDeA-CTR | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $22,861,960 | September 1, 2016 | June 30, 2027 | RIZZO, MATTHEW | reporter.nih.gov |
| Intermediate-sized Expanded Access Protocol for CNM-Au8 in Amyotrophic Lateral Sclerosis (ALS). | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $22,785,879 | September 25, 2023 | August 31, 2027 | ANDREWS, JINSY | reporter.nih.gov |
| NorthStar Node of the NIDA Clinical Trials Network | NIH | National Institute on Drug Abuse | 2021 to 2025 | $22,374,119 | September 1, 2015 | February 29, 2032 | BART, GAVIN | reporter.nih.gov |
| CTSU CORE SUPPORT SERVICES AND THE CTSU ENTERPRISE OF SYSTEMS - TASK AREA II | NIH | National Cancer Institute | 2021 | $22,304,622 | August 31, 2020 | August 30, 2021 | MARTIER, KAREN | reporter.nih.gov |
| Center for Research, Health and Society | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $21,943,481 | September 24, 2021 | June 30, 2027 | CORNELL, CAROL ELLEN | reporter.nih.gov |
| REVEAL - Research Evaluating Vagal Excitation and Anatomical Linkages. | NIH | National Center for Complementary & Integrative Health | 2022 to 2024 | $21,646,919 | September 23, 2022 | August 31, 2025 | OSBORN, JOHN W | reporter.nih.gov |
| UZ-UCSF CTU | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $21,624,239 | September 9, 2025 | November 30, 2027 | CHIRENJE, ZVAVAHERA MIKE | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $21,571,641 | August 1, 1997 | November 30, 2027 | CARPTEN, JOHN D. | reporter.nih.gov |
| UCLA AIDS Prevention and Treatment Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $21,546,764 | February 1, 2007 | November 30, 2027 | LANDOVITZ, RAPHAEL J | reporter.nih.gov |
| Boston HIV CTU | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $21,445,869 | January 15, 2007 | November 30, 2027 | KURITZKES, DANIEL R. | reporter.nih.gov |
| LOGISTICAL AND IT SUPPORT FOR THE NCI CENTRAL INSTITUTIONAL REVIEW BOARD (CIRB) | NIH | National Cancer Institute | 2021 to 2023 | $21,394,060 | September 1, 2019 | August 31, 2024 | VALMONTE, CLAUDINE | reporter.nih.gov |
| Rhode Island IDeA Network of Biomedical Research Excellence | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $21,392,789 | September 30, 2001 | April 30, 2029 | CHO, BONGSUP P | reporter.nih.gov |
| Partnerships for Biomedical Research in Arkansas | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $21,309,096 | September 30, 2001 | April 30, 2026 | CORNETT, LAWRENCE E | reporter.nih.gov |
| Kansas IDeA Network of Biomedical Research Excellence 5 | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $21,278,824 | September 18, 2001 | April 30, 2029 | WRIGHT, DOUGLAS E | reporter.nih.gov |
| Vaccine and Treatment Evaluation Unit at Saint Louis University | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $21,219,564 | December 11, 2019 | November 30, 2026 | HOFT, DANIEL F. | reporter.nih.gov |
| Development of Therapeutic Products for Antibiotic Resistant Bacteria | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $21,157,224 | July 1, 2020 | January 31, 2025 | CIRZ, RYAN | reporter.nih.gov |
| A Phase 2b Clinical Study of the P38 Alpha Kinase Inhibitor Neflamapimod in Patients with Mild-to-Moderate Dementia with Lewy Bodies (DLB) | NIH | National Institute on Aging | 2023 to 2025 | $21,072,036 | February 1, 2023 | January 31, 2026 | ALAM, JOHN | reporter.nih.gov |
| Delaware Clinical and Translational Research ACCEL Program | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $21,011,968 | September 25, 2013 | June 30, 2028 | HICKS, GREGORY E | reporter.nih.gov |
| Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) - Baltimore/Wash DC Center | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $21,007,836 | April 1, 2019 | September 30, 2026 | MARGOLICK, JOSEPH B. | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $20,980,807 | December 1, 1996 | February 28, 2029 | MAITRA, ANIRBAN | reporter.nih.gov |
| University of Massachusetts Center for Clinical and Translational Science | NIH | National Center for Advancing Translational Sciences | 2021 to 2024 | $20,676,306 | August 14, 2015 | May 31, 2026 | LUZURIAGA, KATHERINE F | reporter.nih.gov |
| International Maternal, Adolescent and Pediatric Therapeutics Clinical Trials Network | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $20,605,531 | January 1, 2014 | November 30, 2027 | ALDROVANDI, GRACE M | reporter.nih.gov |
| Specialized Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2024 | $20,560,271 | July 1, 1996 | April 30, 2026 | SIMEONE, DIANE M | reporter.nih.gov |
| Frontiers Clinical and Translational Science Institute at the University of Kansas | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $20,543,509 | September 7, 2017 | June 30, 2027 | CASTRO, MARIO | reporter.nih.gov |
| Yale Center for the Study of Tobacco Product Use and Addiction (YCSTP) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $20,420,182 | September 30, 2013 | August 31, 2028 | KRISHNAN-SARIN, SUCHITRA | reporter.nih.gov |
| Alzheimer's Prevention Initiative ADAD Colombia Trial Program | NIH | National Institute on Aging | 2024 to 2025 | $20,406,409 | September 1, 2024 | August 31, 2029 | ALEXANDER, ROBERT C | reporter.nih.gov |
| MT INBRE: A Multidisciplinary Research Network | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $20,222,717 | September 25, 2001 | April 30, 2029 | BOTHNER, BRIAN P | reporter.nih.gov |
| IDeA Networks of Biomedical Research Excellence in Kentucky | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $20,119,568 | September 30, 2001 | April 30, 2029 | ROUCHKA, ERIC C | reporter.nih.gov |
| Stanford Center for Clinical and Translational Research and Education | NIH | National Center for Advancing Translational Sciences | 2024 to 2025 | $20,074,946 | July 1, 2024 | June 30, 2031 | O'HARA, RUTH M | reporter.nih.gov |
| Cure Sickle Cell | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $19,980,036 | September 28, 2018 | September 30, 2026 | EAPEN, MARY | reporter.nih.gov |
| Vaccine and Treatment Evaluation Units (VTEU) 24-0003 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $19,949,752 | December 11, 2019 | November 30, 2026 | EL SAHLY, HANA M | reporter.nih.gov |
| SUPPORT SERVICES FOR THE PREVENTION AND TREATMENT THROUGH A COMPREHENSIVE CARE CONTINUUM FOR HIV-AFFECTED ADOLESCENTS IN RESOURCE CONSTRAINED SETTINGS IMPLEMENTATION SCIENCE NETWORK | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $19,936,404 | August 25, 2025 | August 24, 2026 | DRIVER, BARBARA | reporter.nih.gov |
| Metro-Minnesota Community Oncology Research Consortium (MMCORC) | NIH | National Cancer Institute | 2021 to 2025 | $19,766,845 | August 1, 2014 | July 31, 2026 | JI, YAN | reporter.nih.gov |
| Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component C: Clinical Core | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $19,720,676 | September 16, 2019 | September 15, 2026 | FRANKENFIELD, JILL | reporter.nih.gov |
| Vermont Biomedical Research Network-Vermont INBRE | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $19,534,463 | September 30, 2001 | June 30, 2030 | FRANCKLYN, CHRISTOPHER S | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $19,528,719 | June 1, 1997 | June 30, 2028 | STEIDL, ULRICH | reporter.nih.gov |
| Johns Hopkins Institute for Clinical and Translational Research | NIH | National Center for Advancing Translational Sciences | 2024 to 2025 | $19,350,081 | May 15, 2024 | April 30, 2031 | FORD, DANIEL ERNEST | reporter.nih.gov |
| Tufts Clinical and Translational Science Institute | NIH | National Center for Advancing Translational Sciences | 2021 to 2022 | $19,335,868 | May 1, 2018 | April 30, 2023 | SELKER, HARRY P. | reporter.nih.gov |
| EPPIC-Net Pain Research - Application for Clinical Trial and Related Activities (OT2) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $19,316,294 | January 1, 2021 | July 31, 2026 | FAVA, MAURIZIO | reporter.nih.gov |
| A Multisectoral Strategy to Address Persistent Drivers of the HIV Epidemic in East Africa | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $18,851,827 | September 25, 2020 | March 31, 2027 | HAVLIR, DIANE V | reporter.nih.gov |
| Expanding HOPE Liver Transplantation: Understanding Opportunistic Infection and Cancer Risk | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $18,807,472 | August 1, 2018 | August 31, 2030 | DURAND, CHRISTINE MARIE | reporter.nih.gov |
| JCOIN Phase II Coordination and Translation Center | NIH | National Institute on Drug Abuse | 2021 to 2025 | $18,785,790 | September 30, 2019 | May 31, 2029 | TAXMAN, FAYE S | reporter.nih.gov |
| Pediatric Brain Tumor Consortium A multi-institutional consortium devoted to novel phase I and II clinical evaluations of experimental treatment approaches for pediatric CNS tumors | NIH | National Cancer Institute | 2021 to 2025 | $18,653,803 | April 1, 1999 | March 31, 2026 | ONAR-THOMAS, ARZU | reporter.nih.gov |
| The Ohio Valley Node of the Clinical Trials Network (CTN-0153) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $18,588,752 | March 1, 2025 | February 29, 2032 | WINHUSEN, T JOHN | reporter.nih.gov |
| Weill Cornell Medicine - Rutgers New Jersey Medical School Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $18,362,120 | January 10, 2007 | November 30, 2027 | GULICK, ROY M. | reporter.nih.gov |
| STORAGE AND DISTRIBUTION OF CLINICAL AGENTS | NIH | National Cancer Institute | 2023 to 2025 | $18,271,500 | February 1, 2023 | January 31, 2026 | MAHZAD, MEHRINFAR | reporter.nih.gov |
| An Expanded Access Protocol of Intravenous Trehalose Injection 90 mg/mL Treatment of Patients with Amyotrophic Lateral Sclerosis | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $18,136,504 | September 28, 2022 | August 31, 2025 | PAGANONI, SABRINA | reporter.nih.gov |
| UCSD Collaborative Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $18,116,542 | December 1, 2024 | November 30, 2027 | WILKIN, TIMOTHY J. | reporter.nih.gov |
| LOGISTICAL AND IT SUPPORT FOR THE NCI CENTRAL INDIVIDUAL REVIEW BOARD (CIRB) | NIH | National Cancer Institute | 2024 to 2025 | $18,014,450 | September 1, 2024 | August 31, 2026 | VALMONTE, CLAUDINE | reporter.nih.gov |
| Penn State Clinical and Translational Science Institute | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $17,955,915 | September 15, 2016 | June 30, 2027 | KRASCHNEWSKI, JENNIFER L. | reporter.nih.gov |
| Heartland Cancer Research NCORP | NIH | National Cancer Institute | 2021 to 2025 | $17,817,032 | August 1, 2014 | July 31, 2026 | FALLER, BRYAN | reporter.nih.gov |
| NIAID VIROLOGY QUALITY ASSURANCE (VQA) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $17,732,468 | June 21, 2025 | June 20, 2026 | DENNY, THOMAS | reporter.nih.gov |
| Northeast Node of the National Drug Abuse Treatment Clinical Trials Network | NIH | National Institute on Drug Abuse | 2021 to 2025 | $17,509,561 | March 1, 2025 | February 28, 2030 | MARSCH, LISA A. | reporter.nih.gov |
| Development of Therapeutic Products for Antibacterial Resistant Infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $17,380,862 | September 9, 2019 | January 31, 2026 | OSCHNER, URS | reporter.nih.gov |
| Kaiser Permanente NCI National Community Oncology Research Program, NCORP | NIH | National Cancer Institute | 2021 to 2025 | $17,245,643 | August 1, 2014 | July 31, 2026 | SUGA, JENNIFER MARIE | reporter.nih.gov |
| Add Health Parent Study: A Biosocial Resource for the Study of Multigenerational Racial/Ethnic Disparities in Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) | NIH | National Institute on Aging | 2023 to 2025 | $17,039,516 | August 15, 2023 | April 30, 2028 | HARRIS, KATHLEEN MULLAN | reporter.nih.gov |
| Emory-CDC CTU | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $16,972,899 | December 1, 2024 | November 30, 2027 | KELLEY, COLLEEN F | reporter.nih.gov |
| Biomarkers of Cognitive Decline Among Normal Individuals: The Biocard Cohort | NIH | National Institute on Aging | 2021 to 2025 | $16,952,609 | July 1, 2009 | May 31, 2027 | ALBERT, MARILYN S. | reporter.nih.gov |
| Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component C: Clinical Core | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $16,914,921 | September 16, 2019 | September 30, 2026 | BERES, WENDELL | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $16,870,049 | August 4, 1997 | November 30, 2029 | DRAGNEV, KONSTANTIN H. | reporter.nih.gov |
| Institute for Integration of Medicine & Science: A Partnership to Improve Health | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $16,712,975 | July 25, 2023 | June 30, 2030 | CLARK, ROBERT A | reporter.nih.gov |
| Research Centers in Minority Institutions (RCMI) Coordinating Center | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2024 | $16,661,265 | September 8, 2020 | April 30, 2026 | OFILI, ELIZABETH O. | reporter.nih.gov |
| The OSU Center for Clinical and Translational Science: Advancing Today's Discoveries to Improve Health | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $16,593,003 | August 22, 2023 | July 31, 2030 | JOHNSON, JULIE A. | reporter.nih.gov |
| South Carolina Clinical & Translational Research Institute (SCTR) | NIH | National Center for Advancing Translational Sciences | 2021 to 2024 | $16,582,090 | August 13, 2015 | April 27, 2025 | BRADY, KATHLEEN T. | reporter.nih.gov |
| 1/2 Pediatric Influence of Cooling duration on Efficacy in Cardiac Arrest Patients (P-ICECAP) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $16,489,352 | September 15, 2021 | August 31, 2028 | MOLER, FRANK W | reporter.nih.gov |
| Assessment of Biomarker Guided CNI Substitution in Kidney Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $16,391,930 | July 1, 2025 | June 30, 2029 | HEEGER, PETER SCOTT | reporter.nih.gov |
| Indiana Clinical and Translational Sciences Institute | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $16,320,212 | September 5, 2025 | June 30, 2026 | MOE, SHARON M | reporter.nih.gov |
| CTSA UM1 Program at University of Utah | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $16,275,324 | April 1, 2023 | March 31, 2030 | HESS, RACHEL | reporter.nih.gov |
| The National Dental PBRN Administrative and Resource Center | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $16,239,544 | June 7, 2019 | May 31, 2027 | GILBERT, GREGG H | reporter.nih.gov |
| Administrative Supplement: The ASCEND (Advancing Skills in Contracting and Execution for NIH-Designated Grants) Initiative | NIH | National Cancer Institute | 2021 to 2025 | $16,211,327 | April 7, 2009 | March 31, 2028 | RAMALINGAM, SURESH S | reporter.nih.gov |
| University of Pennsylvania HIV Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $16,198,927 | February 1, 2007 | November 30, 2027 | FRANK, IAN | reporter.nih.gov |
| Pelvic Floor Disorders Network Data Coordinating Center | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $16,166,829 | August 8, 2011 | June 30, 2027 | GANTZ, MARIE G | reporter.nih.gov |
| Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial (CREST-2) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $16,136,344 | March 15, 2014 | August 31, 2026 | BROTT, THOMAS G | reporter.nih.gov |
| Michigan Cancer Research Consortium NCORP | NIH | National Cancer Institute | 2021 to 2025 | $16,033,140 | August 1, 2014 | July 31, 2026 | AL BAGHDADI, TAREQ | reporter.nih.gov |
| UTMB Clinical and Translational Science Award | NIH | National Center for Advancing Translational Sciences | 2021 to 2024 | $15,990,785 | August 18, 2015 | March 31, 2026 | URBAN, RANDALL J | reporter.nih.gov |
| Brain Oxygen Optimization in Severe Traumatic Brain Injury - Phase 3 (BOOST-3) | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $15,805,224 | July 1, 2018 | November 30, 2025 | BARSAN, WILLIAM G | reporter.nih.gov |
| Biology of the Hormonal Regulation of Cancer and Immuno Oncology Outcomes Research Proposal. | NIH | National Cancer Institute | 2021 to 2025 | $15,746,743 | August 1, 1997 | June 30, 2027 | COUSSENS, LISA M | reporter.nih.gov |
| C3PO - The Candidate Clinical Correlate of Prognostic Outcome for TB Study | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $15,575,398 | July 1, 2024 | May 31, 2026 | NAHID, PAYAM | reporter.nih.gov |
| PERU Clinical Trial Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $15,506,525 | December 1, 2024 | November 30, 2027 | SANCHEZ, JORGE LUIS | reporter.nih.gov |
| NUCATS CTSA UM1 at Northwestern University | NIH | National Center for Advancing Translational Sciences | 2024 to 2025 | $15,503,048 | September 1, 2024 | July 31, 2031 | D'AQUILA, RICHARD | reporter.nih.gov |
| Targeting Inflammation and Alloimmunity in Lung Transplant Recipients With Clazakizumab | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $15,471,597 | September 14, 2021 | June 30, 2028 | MADSEN, JOREN C | reporter.nih.gov |
| Southeast Collaborative for Innovative Solutions to Chronic Diseases | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $15,450,960 | September 24, 2021 | June 30, 2027 | WILKINS, CONSUELO HOPKINS | reporter.nih.gov |
| Catalyzing and Harmonizing Operational Innovation for Recruitment (CHOIR) | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $15,368,227 | July 14, 2023 | August 7, 2028 | HARRIS, PAUL A. | reporter.nih.gov |
| Clarifying the Optimal Application of SLT Therapy (COAST) Trial | NIH | National Eye Institute | 2021 to 2024 | $15,288,624 | September 30, 2020 | August 31, 2025 | WISNIEWSKI, STEPHEN R | reporter.nih.gov |
| Immune signatures of vaccine responses in vulnerable populations | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $15,275,325 | July 12, 2010 | April 30, 2028 | MONTGOMERY, RUTH R | reporter.nih.gov |
| NAC Attack, a phase-3, multicenter, randomized, placebo-controlled trial in patients with retinitis pigmentosa | NIH | National Eye Institute | 2022 to 2025 | $15,187,946 | March 17, 2022 | July 31, 2027 | KONG, XIANGRONG | reporter.nih.gov |
| Upstate Carolina Consortium - Community Oncology Research Program | NIH | National Cancer Institute | 2021 to 2025 | $15,178,307 | May 23, 2025 | July 31, 2026 | CURTIS, AMARINTHIA E | reporter.nih.gov |
| University of Washington Vaccine and Treatment Evaluation Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $15,173,751 | December 11, 2019 | November 30, 2026 | WALD, ANNA | reporter.nih.gov |
| A Phase-2b, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-N-methyl-D-aspartate receptor (NMDAR) Encephalitis and Assess Markers of Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $15,144,108 | September 15, 2021 | August 31, 2027 | CLARDY, STACEY LYNN | reporter.nih.gov |
| PHRU-Setshaba Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $15,110,381 | December 1, 2024 | November 30, 2027 | GRAY, GLENDA E | reporter.nih.gov |
| WOMEN'S HEALTH INITIATIVE - CLINICAL COORDINATING CENTER: TASK AREA B - LONG LIFE STUDY VISIT 2 LIMITED HOME VISIT | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $15,096,788 | March 4, 2022 | March 3, 2024 | ANDERSON, GARNET | reporter.nih.gov |
| Data Coordinating Center for the Pediatric Heart Network | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $15,075,464 | July 1, 2017 | December 31, 2024 | MILLER, JULIE ELAINE | reporter.nih.gov |
| Engaging Cooperative Sites for Trial Acceleration, Trust, Innovation, and Capability (ECSTATIC) | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $15,054,272 | June 29, 2023 | April 30, 2028 | CASEY, JONATHAN DALE | reporter.nih.gov |
| NICHD: R&D: SUPPORTING THE PHASE IIB CLINICAL TRIAL OF SUBCUTANEOUS LEVONORGESTREL BUTANOATE (LB) FOR FEMALE CONTRACEPTION: NON-SEVERABLE | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $15,021,043 | August 1, 2025 | February 28, 2026 | DART, CLINT | reporter.nih.gov |
| The Rhythm Evaluation for Anticoagulation with Continuous Monitoring of Atrial Fibrillation Trial (REACT-AF) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $14,978,926 | August 25, 2022 | July 31, 2029 | PASSMAN, ROD S | reporter.nih.gov |
| Indiana University Melvin and Bren Simon Comprehensive Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $14,928,659 | September 22, 1999 | August 31, 2029 | LEE, KELVIN P. | reporter.nih.gov |
| Autologous chimeric antigen receptor engineered T cell immunotherapy for desensitization in patients awaiting kidney transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $14,843,451 | August 20, 2021 | May 31, 2028 | NAJI, ALI | reporter.nih.gov |
| Johns Hopkins University Trial Innovation Center | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $14,762,337 | July 5, 2023 | April 30, 2028 | HANLEY, DANIEL F | reporter.nih.gov |
| Causes and Consequences of Healthcare Inefficiency in Alzheimer’s Disease and Related Dementias | NIH | National Institute on Aging | 2021 to 2025 | $14,684,279 | August 1, 2001 | July 31, 2028 | BARNATO, AMBER E | reporter.nih.gov |
| The Tisch Cancer Institute - Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $14,629,412 | August 1, 2015 | July 31, 2030 | PARSONS, RAMON E | reporter.nih.gov |
| Global Alzheimer's Platform Trial-Ready Cohort for Preclinical/Prodromal Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2022 | $14,626,193 | May 1, 2017 | April 30, 2024 | AISEN, PAUL S. | reporter.nih.gov |
| Tracking and Engaging Disconnected Long-Term Survivors of Childhood Cancer to Improve Adherence to Evidence-Based Screening Guidelines | NIH | National Cancer Institute | 2021 to 2025 | $14,573,097 | September 5, 1997 | August 31, 2026 | SWEASY, JOANN B. | reporter.nih.gov |
| FVIIa for Acute hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $14,427,244 | March 1, 2020 | December 31, 2026 | BRODERICK, JOSEPH PAUL | reporter.nih.gov |
| Lung Transplant Clinical Trial Network (LT-CTN) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $14,392,000 | June 1, 2025 | May 31, 2028 | PALMER, SCOTT M | reporter.nih.gov |
| Long-term effects of hearing intervention on brain health in the Aging and Cognitive Health Evaluation in Elders (ACHIEVE) randomized study | NIH | National Institute on Aging | 2022 to 2025 | $14,339,100 | August 15, 2022 | July 31, 2028 | DEAL, JENNIFER ANNE | reporter.nih.gov |
| University of Rochester Vaccine and Treatment Evaluation Unit (VTEU) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $14,263,529 | December 11, 2019 | November 30, 2026 | FALSEY, ANN R | reporter.nih.gov |
| 1/2 REPRIEVE Extension for Trial Completion | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $14,219,228 | May 1, 2023 | April 30, 2027 | GRINSPOON, STEVEN K. | reporter.nih.gov |
| Kaiser Washington Vaccine and Treatment Evaluation Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $14,173,633 | December 11, 2019 | November 30, 2026 | JACKSON, LISA A | reporter.nih.gov |
| UNC MACS/WIHS Combined Cohort Study Clinical Research Site | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $13,957,792 | April 1, 2019 | September 30, 2026 | FLORIS-MOORE, MICHELLE | reporter.nih.gov |
| Sleep for Stroke Management And Recovery Trial (Sleep SMART) | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $13,933,376 | August 15, 2018 | April 30, 2027 | BROWN, DEVIN L | reporter.nih.gov |
| NCI Community Oncology Research Program 2025 Extension Request | NIH | National Cancer Institute | 2021 to 2025 | $13,851,882 | August 1, 2014 | July 31, 2026 | IRVIN, WILLIAM J | reporter.nih.gov |
| Wisconsin NCI Community Oncology Research Program (WiNCORP) | NIH | National Cancer Institute | 2021 to 2025 | $13,851,021 | August 1, 2014 | July 31, 2026 | ONITILO, ADEDAYO A | reporter.nih.gov |
| HEAL ERN: Data Coordinating Resource Center | NIH | National Center for Advancing Translational Sciences | 2022 to 2025 | $13,821,158 | September 23, 2022 | August 31, 2027 | WATT, KEVIN M | reporter.nih.gov |
| OUTLAST - A First Multiple-Dose Efficacy Study of IXT-m200, an anti-METH Monoclonal Antibody, in Patients with METH Use Disorder | NIH | National Institute on Drug Abuse | 2021 to 2023 | $13,778,020 | September 30, 2021 | July 31, 2025 | STEVENS, MISTY WARD | reporter.nih.gov |
| Stephenson Cancer Center - Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $13,739,637 | May 1, 2018 | April 30, 2028 | MANNEL, ROBERT S. | reporter.nih.gov |
| Arylepoxamides: A new class of potent, safer analgesics | NIH | National Institute on Drug Abuse | 2021 to 2023 | $13,729,307 | December 15, 2018 | August 31, 2025 | REICH, JEFFREY | reporter.nih.gov |
| Integrated Care for Chronic Pain and Opioid Use Disorder: The IMPOWR Research Center at Montefiore/Einstein (IMPOWR-ME) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $13,727,424 | September 30, 2021 | July 31, 2027 | STARRELS, JOANNA L. | reporter.nih.gov |
| A Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Phase II Study to Evaluate the Safety and Efficacy of CT1812 in Subjects with Mild to Moderate Alzheimerʼs Disease | NIH | National Institute on Aging | 2021 | $13,634,548 | September 15, 2018 | May 31, 2024 | CAGGIANO, ANTHONY O | reporter.nih.gov |
| Together: Transforming and Translating Discovery to Improve Health | NIH | National Center for Advancing Translational Sciences | 2021 to 2024 | $13,611,230 | July 1, 2024 | June 30, 2025 | MITCHELL, DUANE A. | reporter.nih.gov |
| HIV/AIDS Clinical Trials Units University of Cape Town CTU 2020 to 2027 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $13,518,599 | April 1, 2007 | November 30, 2027 | BEKKER, LINDA-GAIL | reporter.nih.gov |
| 1/2 ICECAP: Influence of Cooling duration on Efficacy in Cardiac Arrest Patients | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $13,466,840 | September 19, 2019 | August 31, 2025 | MEURER, WILLIAM JOSEPH | reporter.nih.gov |
| CURE SICKLE CELL INITIATIVE DATA STRATEGY AND DATA RESOURCES PROGRAM | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $13,440,748 | September 28, 2018 | December 31, 2026 | KRONER, BARBARA L | reporter.nih.gov |
| Pediatric Acute Liver Failure Immune Response Network (PALF IRN): Treatment for Immune Mediated Pathophysiology (TRIUMPH) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $13,418,019 | June 15, 2021 | May 31, 2027 | ALONSO, ESTELLA M. | reporter.nih.gov |
| University of Virginia Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $13,417,285 | September 16, 1997 | January 31, 2027 | LOUGHRAN, THOMAS P. | reporter.nih.gov |
| Data, Modeling,and Coordination Center for PrecISE Network | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $13,407,521 | September 23, 2017 | June 30, 2025 | IVANOVA, ANASTASIA | reporter.nih.gov |
| The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site | NIH | National Cancer Institute | 2021 to 2025 | $13,340,451 | August 1, 2025 | July 31, 2026 | DRESCHER, CHARLES | reporter.nih.gov |
| Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $13,340,237 | April 10, 2020 | November 30, 2026 | MULLIGAN, MARK JOSEPH | reporter.nih.gov |
| Prevention of Fractures in Patients with Parkinson's Disease | NIH | National Institute on Aging | 2022 to 2024 | $13,269,734 | September 30, 2018 | February 28, 2026 | CUMMINGS, STEVEN RON | reporter.nih.gov |
| MIND DIET AND DEMENTIA PREVENTION IN ISCHEMIC STROKE PATIENTS | NIH | National Institute on Aging | 2021 to 2025 | $13,186,351 | September 1, 2020 | May 31, 2027 | AGGARWAL, NEELUM T. | reporter.nih.gov |
| Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) | NIH | National Center for Advancing Translational Sciences | 2021 to 2024 | $13,154,158 | August 28, 2015 | March 31, 2026 | VERBALIS, JOSEPH G | reporter.nih.gov |
| Gulf South Clinical Trials Network (Gulf South NCORP) | NIH | National Cancer Institute | 2021 to 2025 | $13,144,481 | August 1, 2014 | July 31, 2026 | OCHOA, AUGUSTO C. | reporter.nih.gov |
| IND-enabling Studies in Support of First in Human Safety Studies of a Novel Anti-Nicotine Human Monoclonal Antibody | NIH | National Institute on Drug Abuse | 2023 to 2025 | $13,125,765 | May 1, 2023 | April 30, 2027 | KALNIK, MATTHEW W | reporter.nih.gov |
| Pitt-Ohio State Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $13,065,770 | February 1, 2007 | November 30, 2027 | RIDDLER, SHARON | reporter.nih.gov |
| The Sylvester Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $13,016,151 | July 10, 2019 | June 30, 2029 | NIMER, STEPHEN D. | reporter.nih.gov |
| Study in Parkinson Disease of Exercise Phase 3 Clinical Trial: SPARX3 | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $13,006,073 | September 25, 2019 | July 31, 2026 | CORCOS, DANIEL M. | reporter.nih.gov |
| Einstein-Montefiore Clinical and Translational Science Award Hub | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $13,001,820 | March 3, 2023 | February 28, 2030 | KAHN, JESSICA | reporter.nih.gov |
| The A3 Study: Ante-Amyloid Prevention of Alzheimer's disease | NIH | National Institute on Aging | 2021 to 2023 | $12,937,549 | August 15, 2016 | April 30, 2024 | SPERLING, REISA A. | reporter.nih.gov |
| Expanding Translational Research in Arkansas | NIH | National Center for Advancing Translational Sciences | 2021 to 2023 | $12,917,071 | July 1, 2019 | August 31, 2024 | JAMES, LAURA P | reporter.nih.gov |
| HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR): Research Centers | NIH | National Institute on Drug Abuse | 2021 to 2025 | $12,902,047 | September 30, 2021 | July 31, 2026 | BECKER, WILLIAM C | reporter.nih.gov |
| HEALTH Center for Addictions Research and Cancer Prevention | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2024 | $12,882,144 | September 8, 2020 | April 30, 2026 | BEECH, BETTINA M. | reporter.nih.gov |
| Vanderbilt HIV Clinical Trials Unit (CTU) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $12,733,650 | February 1, 2007 | November 30, 2027 | HAAS, DAVID W | reporter.nih.gov |
| Case Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $12,725,521 | December 1, 2024 | November 30, 2027 | YENDEWA, GEORGE | reporter.nih.gov |
| Supporting Treatment Access and Recovery for Co-Occurring Opioid Use and Mental Health Disorders (STAR-COD) | NIH | National Institute of Mental Health | 2021 to 2024 | $12,719,359 | September 16, 2021 | August 31, 2025 | SMELSON, DAVID A | reporter.nih.gov |
| Collaborative Pediatric Critical Care Research Network | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $12,717,344 | August 13, 2021 | July 31, 2026 | WATT, KEVIN M | reporter.nih.gov |
| Clinical Trial Data Processing, Analysis, and Coordination Center (CT-DPACC) for Accelerating Medicines Partnership Schizophrenia (AMP SCZ) Project | NIH | National Institute of Mental Health | 2024 to 2025 | $12,671,179 | June 17, 2024 | May 31, 2029 | SHENTON, MARTHA E. | reporter.nih.gov |
| Tailored Retention and Engagement for Effective integrated Treatment of OUD and Pain (TREETOP) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $12,656,947 | September 30, 2021 | July 31, 2027 | WINSTANLEY, ERIN L | reporter.nih.gov |
| A Randomized, Double-Blind, Placebo-Controlled Study of LHP588 in Subjects with P. gingivalis-Positive Alzheimer's Disease | NIH | National Institute on Aging | 2025 | $12,591,952 | August 15, 2025 | July 31, 2029 | DETKE, MICHAEL J. | reporter.nih.gov |
| Phase 2 Randomized, Double-Blind, Placebo-Controlled Clinical Trial of T3D-959 in Mild to Moderate Alzheimer's Disease Subjects | NIH | National Institute on Aging | 2021 to 2022 | $12,573,346 | May 1, 2019 | February 28, 2023 | DIDSBURY, JOHN | reporter.nih.gov |
| Center for Addiction and Disease Risk Exacerbation | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $12,487,946 | August 1, 2019 | July 31, 2029 | MONTI, PETER M. | reporter.nih.gov |
| Georgetown University Lombardi Comprehensive Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $12,475,608 | July 1, 2025 | June 30, 2026 | WEINER, LOUIS M. | reporter.nih.gov |
| CURE CTU | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $12,461,433 | January 1, 2007 | November 30, 2027 | SPECTOR, STEPHEN A | reporter.nih.gov |
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $12,342,542 | February 1, 1997 | January 31, 2027 | MESA, RUBEN A. | reporter.nih.gov |
| Impacts of receiving Alzheimer's disease genetic risk information among Latinos in northern Manhattan | NIH | National Institute on Aging | 2021 to 2024 | $12,295,034 | February 15, 2020 | November 30, 2025 | OTTMAN, RUTH | reporter.nih.gov |
| Columbia Collaborative HIV/AIDS Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $12,286,513 | February 1, 2007 | November 30, 2027 | SOBIESZCZYK, MAGDALENA ELZBIETA | reporter.nih.gov |
| Phase III double-blind, randomized controlled trial of suvorexant versus placebo to treat insomnia in persons with opioid use disorder | NIH | National Institute on Drug Abuse | 2024 to 2025 | $12,205,195 | May 15, 2024 | February 28, 2027 | HUHN, ANDREW S | reporter.nih.gov |
| Cincinnati Children's Hospital Medical Center Vaccine and Treatment Evaluation Units (UM1 Clinical Trial Required) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $12,115,898 | December 11, 2019 | November 30, 2026 | FRENCK, ROBERT WILSON | reporter.nih.gov |
| StrokeNet Thrombectomy Endovascular Platform (STEP) | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $12,112,868 | September 1, 2022 | February 28, 2026 | ELM, JORDAN J. | reporter.nih.gov |
| University of Iowa Institute for Clinical and Translational Science | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $12,092,430 | April 1, 2023 | March 31, 2030 | WINOKUR, PATRICIA | reporter.nih.gov |
| Center for Research and Education on Aging and Technology Enhancement - CREATE | NIH | National Institute on Aging | 2022 to 2025 | $12,069,399 | June 15, 2022 | May 31, 2027 | CZAJA, SARA J | reporter.nih.gov |
| Nutrition for Precision Health: The University of North Carolina at Chapel Hill Clinical Center | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $12,065,421 | December 10, 2021 | November 30, 2026 | MAYER-DAVIS, ELIZABETH J | reporter.nih.gov |
| Evaluation of safety and pharmacokinetics of naltrexone implant | NIH | National Institute on Drug Abuse | 2021 to 2023 | $12,060,583 | September 15, 2018 | February 28, 2026 | BISAGA, ADAM | reporter.nih.gov |
| A Safety and Efficacy Study of AAV2-hAADC for AADC Deficiency | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $12,060,518 | September 15, 2016 | August 31, 2027 | BANKIEWICZ, KRYSTOF S | reporter.nih.gov |
| Beta1-selective blockade for prevention of postmenopausal bone loss: A randomized controlled trial | NIH | National Institute on Aging | 2021 to 2025 | $12,029,156 | January 1, 2021 | December 31, 2026 | KHOSLA, SUNDEEP | reporter.nih.gov |
| Miami Clinical and Translational Science Institute | NIH | National Center for Advancing Translational Sciences | 2023 to 2025 | $11,973,000 | August 18, 2023 | June 30, 2030 | CARRASQUILLO, OLVEEN | reporter.nih.gov |
| A Placebo-Controlled Effectiveness in INPH Shunting (PENS) Trial | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $11,962,900 | September 30, 2021 | July 31, 2027 | LUCIANO, MARK GREGORY | reporter.nih.gov |
| Clinical Development of a Therapeutic Agent for Rapid Reversal of Methamphetamine Intoxication | NIH | National Institute on Drug Abuse | 2023 to 2025 | $11,962,715 | August 15, 2023 | June 30, 2026 | LI, XINHUA | reporter.nih.gov |
| DIAN-TU: Next Generation Prevention Trial | NIH | National Institute on Aging | 2022 to 2023 | $11,960,034 | September 1, 2017 | May 31, 2024 | BATEMAN, RANDALL J | reporter.nih.gov |
| Clinical and Translational Science Collaborative of Cleveland | NIH | National Center for Advancing Translational Sciences | 2021 to 2022 | $11,907,099 | May 15, 2018 | September 30, 2023 | MCCOMSEY, GRACE A | reporter.nih.gov |
| Wake Forest Clinical and Translational Science Award | NIH | National Center for Advancing Translational Sciences | 2021 to 2023 | $11,901,656 | August 13, 2015 | August 31, 2024 | ROSENTHAL, GARY E | reporter.nih.gov |
| Scalable Expanded Access with Analysis of Neurofilament and Other Biomarkers for Ibudilast in ALS (SEA-NOBI-ALS) | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $11,846,278 | September 1, 2024 | August 31, 2028 | OSKARSSON, BJORN E | reporter.nih.gov |
| Targeting the B Cell Response to Treat Antibody-Mediated Rejection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $11,789,092 | August 20, 2021 | May 31, 2028 | KNECHTLE, STUART JOHNSTON | reporter.nih.gov |
| Integrated Therapies for Alcohol use in Alcohol-associated Liver Disease (ITAALD) - Indiana University Data Coordinating Center | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $11,773,646 | August 1, 2018 | June 30, 2029 | TU, WANZHU | reporter.nih.gov |
| REVERSE-Long COVID: A Multicenter Randomized, Placebo-Controlled Clinical Trial of Immunomodulation (with Baricitinib) for Long COVID Related ADRD | NIH | National Institute on Aging | 2024 to 2025 | $11,773,020 | January 1, 2024 | December 31, 2028 | ELY, E WESLEY | reporter.nih.gov |
| COBRE Center on Opioids and Overdose | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $11,768,169 | September 1, 2018 | August 31, 2028 | RICH, JOSIAH D | reporter.nih.gov |
| A once-weekly oral methadone for maintenance therapy for opioid use disorder | NIH | National Institute on Drug Abuse | 2021 | $11,699,793 | September 30, 2019 | April 30, 2025 | SCRANTON, RICHARD | reporter.nih.gov |
| Medical University of South Carolina - Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2025 | $11,675,386 | April 1, 2009 | March 31, 2029 | DUBOIS, RAYMOND N. | reporter.nih.gov |
| NATIENS: A Phase III Randomized Double Blinded Study to Determine the Mechanisms and Optimal Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $11,660,249 | July 15, 2020 | October 31, 2025 | PHILLIPS, ELIZABETH | reporter.nih.gov |
| Cross Sectional and Longitudinal Racial Disparity in Molecular Biomarkers of Alzheimer Disease | NIH | National Institute on Aging | 2021 to 2024 | $11,652,217 | June 1, 2020 | March 31, 2026 | XIONG, CHENGJIE | reporter.nih.gov |
| Scripps Translational Science Institute | NIH | National Center for Advancing Translational Sciences | 2021 to 2022 | $11,650,904 | May 1, 2018 | June 30, 2023 | TOPOL, ERIC JEFFREY | reporter.nih.gov |
| Intermediate-sized Expanded Access Protocol for CNM-Au8 in Amyotrophic Lateral Sclerosis (ALS). | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $11,639,047 | September 25, 2023 | August 31, 2027 | ANDREWS, JINSY | reporter.nih.gov |
| Center for Childhood Obesity Prevention | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $11,539,521 | August 1, 2016 | July 31, 2027 | BORSHEIM, ELISABET | reporter.nih.gov |
| Consortium for Translational and Precision Health | NIH | National Center for Advancing Translational Sciences | 2024 to 2025 | $11,411,362 | September 1, 2024 | July 31, 2031 | KANWAL, FASIHA | reporter.nih.gov |
| Cancer Research Consortium of West Michigan (CRCWM) | NIH | National Cancer Institute | 2021 to 2025 | $11,366,311 | August 8, 2014 | July 31, 2026 | BUTLER, KATHLEEN YOST | reporter.nih.gov |
| The integrated Translational Health Research Institute of Virginia (iTHRIV): Using Data to Improve Health | NIH | National Center for Advancing Translational Sciences | 2021 to 2023 | $11,356,955 | February 27, 2019 | September 30, 2025 | JOHNSTON, KAREN C. | reporter.nih.gov |
| Remote Monitoring and Virtual Collaborative Care for Hypertension Control to Prevent Cognitive Decline | NIH | National Institute on Aging | 2021 to 2024 | $11,354,079 | August 1, 2020 | July 31, 2025 | GUPTA, ADITI | reporter.nih.gov |
| KwaZulu-Natal Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $11,302,268 | December 1, 2024 | November 30, 2027 | ABDOOL KARIM, QUARRAISHA | reporter.nih.gov |
| University of Hawaii Cancer Center CCSG | NIH | National Cancer Institute | 2021 to 2025 | $11,301,895 | July 1, 1997 | July 31, 2029 | UENO, NAOTO T. | reporter.nih.gov |
| Advancing Transplantation Outcomes in Children | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $11,293,854 | July 1, 2025 | June 30, 2028 | BRISCOE, DAVID M. | reporter.nih.gov |
| Clinical Development of COVID-19 Therapeutics | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $11,286,393 | September 22, 2023 | February 15, 2026 | WANG, STANLEY | reporter.nih.gov |
| Pre-Symptomatic Familial ALS (Pre-fALS) Study: From Prodrome and Biomarkers to ALS/FTD Prevention | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $11,282,768 | September 15, 2018 | July 31, 2029 | BENATAR, MICHAEL | reporter.nih.gov |
| NJ ACTS: A Platform for Translational Science in New Jersey | NIH | National Center for Advancing Translational Sciences | 2024 to 2025 | $11,270,857 | May 1, 2024 | April 30, 2031 | PANETTIERI, REYNOLD ALEXANDER | reporter.nih.gov |
| Advanced Development of Vaccine Candidates for Antibiotic Resistant Bacteria | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $11,268,155 | September 1, 2020 | March 31, 2027 | MALINOWSKI, FRANK | reporter.nih.gov |
| The Johns Hopkins University-Blantyre Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $11,246,510 | February 15, 2007 | November 30, 2027 | TAHA, TAHA E | reporter.nih.gov |
| California Partnership for Personalized Nutrition | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $11,224,088 | December 10, 2021 | November 30, 2026 | ADAMS, SEAN HARRISON | reporter.nih.gov |
| Carle Cancer Center NCI Community Oncology Research Program (NCORP) | NIH | National Cancer Institute | 2021 to 2025 | $11,214,272 | August 8, 2014 | July 31, 2026 | ROWLAND, KENDRITH MARTIN | reporter.nih.gov |
| Wits HIV Research Group CLINICAL TRIAL UNIT (CTU) reapplication | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $11,202,199 | March 15, 2007 | September 21, 2025 | SANNE, IAN MATTHIAS | reporter.nih.gov |
| Center for Clinical and Translational Sciences | NIH | National Center for Advancing Translational Sciences | 2024 to 2025 | $11,187,532 | July 24, 2024 | June 30, 2031 | MCPHERSON, DAVID D | reporter.nih.gov |
| From Nerve to Brain: Toward a Mechanistic Understanding of Spinal Cord Stimulation in Human Subjects | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $11,100,837 | September 22, 2022 | August 31, 2027 | WAINGER, BRIAN JASON | reporter.nih.gov |
| The IGNITE II CC: Engagement, Coordination, Demonstration, and Dissemination | NIH | National Human Genome Research Institute | 2021 to 2024 | $11,057,050 | September 22, 2018 | June 30, 2025 | WYATT, CHRISTINA M | reporter.nih.gov |
| Indiana Clinical and Translational Sciences Institute | NIH | National Center for Advancing Translational Sciences | 2021 to 2022 | $11,000,424 | May 18, 2018 | April 30, 2023 | MOE, SHARON M | reporter.nih.gov |
| Johns Hopkins University Baltimore India Clinical Trail Unit (JHUBI CTU) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $10,947,708 | February 5, 2007 | November 30, 2027 | GUPTA, AMITA | reporter.nih.gov |
| Utility of Biomarkers of Rejection and Kidney Injury in Tailoring Liver Transplant Immunosuppression | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $10,920,671 | September 6, 2021 | June 30, 2028 | BOIKE, JUSTIN | reporter.nih.gov |
| A Seamless Phase 2A-B Randomized Double Blind Placebo Controlled Trial to Evaluate the Efficacy and Safety of PQ 912 in Patients with Early Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2023 | $10,874,349 | April 1, 2019 | June 30, 2025 | FELDMAN, HOWARD | reporter.nih.gov |
| Advanced Development of a Universal Influenza Vaccine | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $10,853,574 | September 9, 2019 | April 24, 2025 | LOCHER, CHRISTOPHER | reporter.nih.gov |
| Longitudinal Imaging Biomarkers of Prodromal DLB | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $10,821,041 | September 25, 2017 | August 31, 2027 | KANTARCI, KEJAL | reporter.nih.gov |
| Cancer Research of Wisconsin and Northern Michigan (CROWN) Consortium | NIH | National Cancer Institute | 2021 to 2025 | $10,811,170 | August 23, 2019 | July 31, 2026 | JASLOWSKI, ANTHONY J | reporter.nih.gov |
| AIDS Clinical Trials Group (ACTG) DMC Activities | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $10,797,892 | December 1, 2020 | November 30, 2027 | MAGNUS, MANYA | reporter.nih.gov |
| CLINICAL TRIALS MONITORING SERVICE | NIH | National Cancer Institute | 2021 | $10,790,968 | May 1, 2017 | April 30, 2021 | ANDERSON, BARRY | reporter.nih.gov |
| Liver Cirrhosis Network: Scientific and Data Coordination Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $10,655,826 | August 28, 2021 | July 31, 2027 | SMITH, ABIGAIL | reporter.nih.gov |
| Phase II COBRE in Mesenchymal and Neural Regulation of Metabolic Networks | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $10,635,678 | September 1, 2017 | August 31, 2028 | LIAW, LUCY | reporter.nih.gov |
| Greater Intermountain Node (CTN-0138) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $10,595,733 | March 1, 2025 | February 29, 2032 | COCHRAN, GERALD T. | reporter.nih.gov |
| Arterial Stiffness, Cognition, and Equol (ACE) | NIH | National Institute on Aging | 2022 to 2025 | $10,581,052 | February 15, 2022 | January 31, 2027 | SEKIKAWA, AKIRA | reporter.nih.gov |
| STORAGE AND DISTRIBUTION OF CLINICAL AGENTS | NIH | National Cancer Institute | 2021 to 2022 | $10,577,768 | February 1, 2018 | January 31, 2023 | MEHRINFAR, MAHZAD | reporter.nih.gov |
| Addressing risk through Community Treatment for Infectious disease and Opioid use disorder Now (ACTION) among justice-involved populations | NIH | National Institute on Drug Abuse | 2021 to 2025 | $10,550,278 | September 30, 2020 | July 31, 2026 | SPRINGER, SANDRA ANN | reporter.nih.gov |
| VCID Biomarkers Coordinating Center | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $10,493,954 | September 30, 2016 | June 30, 2027 | GREENBERG, STEVEN M | reporter.nih.gov |
| A sequenced-strategy for improving outcomes in patients with knee osteoarthritis pain | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $10,487,739 | September 25, 2019 | August 31, 2025 | CAMPBELL, CLAUDIA MICHELLE | reporter.nih.gov |
| Integrative Treatment for Achieving Holistic Recovery from Comorbid Chronic Pain and Opioid Use Disorder | NIH | National Institute on Drug Abuse | 2021 to 2025 | $10,475,915 | September 30, 2021 | July 31, 2027 | WITKIEWITZ, KATIE A | reporter.nih.gov |
| ICAP Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $10,475,165 | December 1, 2020 | November 30, 2027 | EL-SADR, WAFAA M. | reporter.nih.gov |
| National Dental Practice-Based Research Network: Coordinating Center | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2025 | $10,434,648 | June 7, 2019 | May 31, 2027 | MCMULLEN, CARMIT KURN | reporter.nih.gov |
| SPORE in Brain Cancer | NIH | National Cancer Institute | 2021 to 2025 | $10,413,880 | September 1, 2008 | August 31, 2029 | LANG, FREDERICK F | reporter.nih.gov |
| MSK SPORE in Genomic Instability in Breast Cancer | NIH | National Cancer Institute | 2021 to 2025 | $10,402,609 | August 13, 2020 | July 31, 2026 | POWELL, SIMON N. | reporter.nih.gov |
| Continuation of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $10,346,124 | September 25, 2012 | July 31, 2025 | KRAUSE-STEINRAUF, HEIDI | reporter.nih.gov |
| CTSA UM1 Program at University of California San Diego Altman Clinical and Translational Research Institute | NIH | National Center for Advancing Translational Sciences | 2025 | $10,325,540 | August 1, 2025 | April 30, 2032 | SMITH, DAVID MITCHELL | reporter.nih.gov |
| Safety/Tolerability/Immunogenicity of first-in-human Aβ DNA vaccine, AV-1959D Phase 1 trials in early-stage AD subjects: based on IND18953 cleared by FDA. | NIH | National Institute on Aging | 2022 to 2025 | $10,320,460 | February 15, 2022 | January 31, 2027 | AGADJANYAN, MICHAEL G | reporter.nih.gov |
| Cannabidiol in the treatment of opioid use disorder | NIH | National Institute on Drug Abuse | 2024 | $10,316,590 | September 30, 2019 | August 31, 2027 | HURD, YASMIN L. | reporter.nih.gov |
| Nutrition Precision Health for All of Us (Chicago Center) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $10,228,129 | December 10, 2021 | November 30, 2026 | VAN HORN, LINDA VERNER | reporter.nih.gov |
| University of Rochester HIV/AIDS Clinical Trials Unit Administrative Supplement | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $10,156,163 | August 26, 2025 | November 30, 2027 | KEEFER, MICHAEL C | reporter.nih.gov |
| New Jersey Alliance for Clinical Translational Science: NJ ACTS | NIH | National Center for Advancing Translational Sciences | 2021 to 2022 | $10,150,629 | March 11, 2019 | February 28, 2023 | PANETTIERI, REYNOLD ALEXANDER | reporter.nih.gov |
| ACTIVE MIND: An adaptive clinical trial of cognitive training to improve function and delay dementia | NIH | National Institute on Aging | 2022 to 2023 | $10,112,651 | September 1, 2022 | June 24, 2024 | O'BRIEN, JENNIFER LEE | reporter.nih.gov |
| The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study | NIH | National Cancer Institute | 2021 to 2025 | $10,080,862 | June 23, 2015 | March 31, 2026 | CERHAN, JAMES R | reporter.nih.gov |
| The International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial EXTENDed Follow-up (EXTEND) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $10,079,314 | April 1, 2021 | March 31, 2027 | HOCHMAN, JUDITH S | reporter.nih.gov |
| Colorado Head and Neck Cancer SPORE | NIH | National Cancer Institute | 2021 to 2025 | $10,073,085 | September 1, 2021 | August 31, 2026 | JIMENO, ANTONIO | reporter.nih.gov |
| Thailand HIV/AIDS and Infectious Disease Clinical Trials Unit (THAI CTU) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $10,070,868 | March 15, 2007 | November 30, 2027 | SUPPARATPINYO, KHUANCHAI | reporter.nih.gov |
| StATins Use in intRacerebral hemorrhage patieNts (SATURN) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $10,035,219 | September 1, 2019 | February 29, 2028 | SELIM, MAGDY H | reporter.nih.gov |
| Advanced Development of a Multivalent Vaccine Candidate for Lassa Fever | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $9,931,387 | September 1, 2017 | January 31, 2027 | SCHNELL, MATTHIAS JOHANNES | reporter.nih.gov |
| The Pacific Northwest Prostate Cancer SPORE | NIH | National Cancer Institute | 2021 to 2025 | $9,924,776 | September 19, 2002 | August 31, 2028 | NELSON, PETER S | reporter.nih.gov |
| The Military HIV Research Program (MHRP) Clinical Trial Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $9,910,676 | December 10, 2013 | November 30, 2027 | ROBB, MERLIN L | reporter.nih.gov |
| The Johns Hopkins University - Uganda Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $9,910,249 | February 5, 2007 | November 30, 2027 | FOWLER, MARY GLENN | reporter.nih.gov |
| LifeâÂÂs end Benefits of CannaBidol and TetrahYdrocannabinol (LiBBY) Trial | NIH | National Institute on Aging | 2021 to 2022 | $9,892,823 | September 15, 2020 | April 30, 2026 | MINTZER, JACOBO | reporter.nih.gov |
| PF614-MPAR: clinical development of opioid with oral overdose protection | NIH | National Institute on Drug Abuse | 2024 to 2025 | $9,861,616 | September 1, 2024 | May 31, 2027 | KIRKPATRICK, LYNN | reporter.nih.gov |
| Georgia NCI Community Oncology Research Program (GA NCORP) | NIH | National Cancer Institute | 2021 to 2025 | $9,828,045 | August 9, 2014 | July 31, 2026 | CANTUARIA, GUILHERME | reporter.nih.gov |
| Botswana-Harvard T.H. Chan School of Public Health AIDS Initiative Partnership CTU | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $9,824,534 | February 1, 2007 | June 30, 2025 | LOCKMAN, SHAHIN | reporter.nih.gov |
| Yale SPORE in Skin Cancer | NIH | National Cancer Institute | 2021 to 2025 | $9,801,266 | June 1, 2006 | August 31, 2028 | BOSENBERG, MARCUS W | reporter.nih.gov |
| CP-CTNet Coordinating Center Year 6 - Aug 1, 2024 through July 31, 2025 | NIH | National Cancer Institute | 2021 to 2024 | $9,786,857 | September 20, 2019 | July 31, 2025 | EICKHOFF, JENS | reporter.nih.gov |
| Sickle Cell Disease and Cardiovascular Risk- Red Cell Exchange SCD-CARRE | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $9,739,425 | September 1, 2022 | April 30, 2027 | GLADWIN, MARK T | reporter.nih.gov |
| Thalamocortical Responsive Neurostimulation for the Treatment of Lennox-Gastaut Syndrome | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $9,737,772 | June 1, 2021 | May 31, 2027 | MORRELL, MARTHA J | reporter.nih.gov |
| GHESKIO Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $9,655,243 | February 1, 2007 | November 30, 2027 | PAPE, JEAN WILLIAM | reporter.nih.gov |
| Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant candidates (COLT) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $9,640,870 | August 26, 2021 | September 30, 2024 | LIMAYE, ABHIJIT PRAKASH | reporter.nih.gov |
| Chronic Pancreatitis Clinical Research Consortium (CPCRC) Data Coordinating Center (CPCRC-DCC) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $9,632,234 | September 28, 2015 | June 30, 2030 | LI, LIANG | reporter.nih.gov |
| Aurora NCORP Community Site | NIH | National Cancer Institute | 2021 to 2025 | $9,617,195 | August 15, 2014 | July 31, 2026 | SAPHNER, THOMAS J | reporter.nih.gov |
| Southern Consortium Node of the Clinical Trials Network (TMS for CUD) | NIH | National Institute on Drug Abuse | 2021 to 2025 | $9,579,585 | March 1, 2025 | February 29, 2032 | BARTH, KELLY S. | reporter.nih.gov |
| Task B1: Phase I Clinical Trial to Evaluate a Therapeutic for Antibiotic Resistant Infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $9,576,633 | May 13, 2021 | January 31, 2025 | BURMAN, BRIDGETT | reporter.nih.gov |
| Tissue destruction and healing in Celiac Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $9,512,977 | September 15, 2022 | July 31, 2027 | JABRI, BANA | reporter.nih.gov |
| CNS Effects of Alcohol: Cellular Neurobiology | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $9,489,642 | December 1, 1983 | December 31, 2027 | ROBERTO, MARISA | reporter.nih.gov |
| Impact of Intensive Treatment of Systolic Blood Pressure on Brain Perfusion, Amyloid and Tau in Older Adults (IPAT-study) | NIH | National Institute on Aging | 2022 to 2025 | $9,488,371 | August 1, 2022 | July 31, 2027 | ZHANG, RONG | reporter.nih.gov |
| Thin, High-Density, High-Performance, Depth and Surface Microelectrodes for Diagnosis and Treatment of Epilepsy | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $9,482,559 | September 1, 2021 | August 31, 2027 | DAYEH, SHADI | reporter.nih.gov |
| BEACH: Biomarker and Edema Attenuation in IntraCerebral Hemorrhage Phase 2a Trial | NIH | National Institute on Aging | 2021 to 2025 | $9,481,336 | February 15, 2021 | November 30, 2026 | HANLEY, DANIEL F | reporter.nih.gov |
| Effects of Successful OSA TreatmENT on Memory and AD BIomarkers in Older AduLts (ESSENTIAL) | NIH | National Institute on Aging | 2025 | $9,466,491 | September 1, 2023 | August 31, 2028 | STONE, KATIE L | reporter.nih.gov |
| Perinatal Arterial Stroke: A Multi-site RCT of Intensive Infant Rehabilitation (I-ACQUIRE) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $9,464,743 | February 1, 2019 | January 31, 2026 | RAMEY, SHARON LANDESMAN | reporter.nih.gov |
| Clinical Trial Advancement and Development for Sarcomas | NIH | National Cancer Institute | 2022 to 2025 | $9,446,195 | September 11, 1997 | January 31, 2027 | VAN ETTEN, RICHARD A. | reporter.nih.gov |
| Tulane COBRE for Clinical and Translational Research in Cardiometabolic Diseases | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $9,439,774 | March 10, 2016 | June 30, 2027 | MILLS, KATHERINE TERESA | reporter.nih.gov |
| Predicting and Understanding the Use of Nicotine Products In a Rapidly Evolving Nicotine Marketplace: The International Nicotine Product, Policy, and Market (INPAM) Study | NIH | National Cancer Institute | 2021 to 2025 | $9,428,812 | April 19, 2016 | August 31, 2026 | CUMMINGS, KENNETH MICHAEL | reporter.nih.gov |
| Yale Head and Neck Cancer SPORE: Overcoming Treatment Resistance in Head and Neck Cancer | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2024 | $9,412,704 | September 22, 2020 | June 30, 2026 | BURTNESS, BARBARA | reporter.nih.gov |
| 1/2 Prospective tReatment EffiCacy in IPF uSlng genOtype for Nac Selection (PRECISIONS) trial and Molecular Endophenotyping in Idiopathic Pulmonary Fibrosis and Interstitial Lung Diseases study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $9,400,136 | September 1, 2020 | June 25, 2024 | MARTINEZ, FERNANDO J | reporter.nih.gov |
| A novel therapeutic to ameliorate chronic pain and reduce opiate use | NIH | National Institute on Drug Abuse | 2021 to 2024 | $9,323,255 | March 15, 2019 | June 30, 2024 | TABAKOFF, BORIS | reporter.nih.gov |
| Ketamine Add-On for Established Status Epilepticus Treatment Trial (KESETT) | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $9,296,510 | January 15, 2025 | December 31, 2026 | KAPUR, JAIDEEP | reporter.nih.gov |
| Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study | NIH | National Cancer Institute | 2021 to 2025 | $9,251,154 | September 19, 2016 | August 31, 2026 | ULRICH, CORNELIA M | reporter.nih.gov |
| An Encyclopedia of the Adipose Tissue Secretome to Identify Mediators of Health and Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $9,233,323 | July 15, 2021 | June 30, 2026 | COHEN, PAUL | reporter.nih.gov |
| Institutional Career Development Core | NIH | National Center for Advancing Translational Sciences | 2021 to 2025 | $9,212,815 | July 18, 2016 | June 30, 2026 | SARKAR, URMIMALA | reporter.nih.gov |
| Utah Trial Innovation Center | NIH | National Center for Advancing Translational Sciences | 2021 to 2022 | $9,192,972 | July 1, 2016 | June 30, 2023 | DEAN, JONATHAN MICHAEL | reporter.nih.gov |
| Development of a novel drug for treating opioid use disorder | NIH | National Institute on Drug Abuse | 2022 to 2024 | $9,160,866 | March 15, 2019 | August 31, 2025 | SHAH, NIKEJ | reporter.nih.gov |
| Global Network for Women's and Children's Health Research Data Coordinating Center | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $9,151,864 | July 1, 2017 | June 30, 2030 | MCCLURE, ELIZABETH M | reporter.nih.gov |
| The Care Ecosystem Response to COVID-19: Accelerating Research on Dementia Care that Meets the Needs of Caregivers and Persons with Dementia during COVID-19 | NIH | National Institute on Aging | 2022 to 2024 | $9,143,854 | June 15, 2022 | May 31, 2026 | POSSIN, KATHERINE LAUREL | reporter.nih.gov |
| Vendor Audit Support Through the Comprehensive and Rapid Response to NIAID Research Programs (CARRRP) Contract | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $9,114,944 | September 16, 2024 | August 31, 2029 | WRIGHT, TED | reporter.nih.gov |
| Anticoagulation in ICH Survivors for Prevention and Recovery (ASPIRE) | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $9,111,057 | July 1, 2019 | April 30, 2027 | SHETH, KEVIN NAVIN | reporter.nih.gov |
| Translational Research in Breast Cancer | NIH | National Cancer Institute | 2021 to 2025 | $9,097,808 | September 19, 2014 | July 31, 2026 | ZHANG, XIANG | reporter.nih.gov |
| MoTrPAC DXA Quality Control | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $9,075,021 | September 15, 2025 | August 31, 2026 | KRAUS, WILLIAM E | reporter.nih.gov |
| Resilience and brain health of older adults | NIH | National Institute on Aging | 2021 to 2025 | $9,066,206 | August 15, 2021 | May 31, 2027 | LENZE, ERIC J | reporter.nih.gov |
| Fragmented early-life experiences, aberrant circuit maturation, emotional vulnerabilities | NIH | National Institute of Mental Health | 2021 to 2023 | $9,060,652 | June 17, 2013 | March 31, 2025 | BARAM, TALLIE Z. | reporter.nih.gov |
| Integrative Center for Precision Nutrition and Human Health | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $9,024,428 | March 20, 2022 | January 31, 2027 | BERRY, MARLA J | reporter.nih.gov |
| Digital, Limited Interaction Efficacy Trial of LifeSkills Mobile to Reduce HIV Incidence | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $9,011,446 | March 9, 2021 | February 28, 2027 | MIMIAGA, MATTHEW JAMES | reporter.nih.gov |
| A-Z Clinical Trials Unit | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $8,989,738 | February 1, 2007 | November 30, 2027 | GOEPFERT, PAUL A. | reporter.nih.gov |
| A Lead Academic Participating Site in Oklahoma for the Design and Conduct of NCTN Clinical Trials | NIH | National Cancer Institute | 2021 to 2025 | $8,980,562 | March 7, 2019 | February 28, 2026 | FURQAN, MUHAMMAD | reporter.nih.gov |
| Prevention Research Center: Parenting Among Women Who Are Opioid Users | NIH | National Institute on Drug Abuse | 2021 to 2023 | $8,972,150 | August 15, 2019 | May 31, 2025 | LEVE, LESLIE DIANE | reporter.nih.gov |
| Johns Hopkins-Tufts Trial Innovation Center HEAL Pain ERN Supplement | NIH | National Center for Advancing Translational Sciences | 2021 to 2022 | $8,842,412 | July 1, 2016 | June 30, 2023 | HANLEY, DANIEL F | reporter.nih.gov |
| UAB Precision Nutrition Clinical Center | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $8,773,942 | December 10, 2021 | November 30, 2026 | HILL, JAMES O | reporter.nih.gov |
| Development of Therapeutic Candidates for Biodefense, Infections and Emerging Infectious Diseases | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $8,743,439 | September 25, 2023 | June 24, 2024 | RAMSTEDT, URBAN | reporter.nih.gov |
| Improving Clinical trial Education, Recruitment, and Enrollment at CTSA Hubs (I-CERCH) - HEAL Supplement | NIH | National Center for Advancing Translational Sciences | 2021 to 2022 | $8,727,151 | July 1, 2016 | June 30, 2023 | HARRIS, PAUL A. | reporter.nih.gov |
| Delaware Christiana Care NCORP | NIH | National Cancer Institute | 2021 to 2025 | $8,723,018 | August 1, 2014 | July 31, 2026 | MASTERS, GREGORY A | reporter.nih.gov |
| Development of PPL-138, a Novel Mixed NOP/Mu Partial Agonist for Treatment of CocaineUse Disorder | NIH | National Institute on Drug Abuse | 2022 to 2024 | $8,683,509 | September 30, 2022 | July 31, 2025 | TOLL, LAWRENCE R | reporter.nih.gov |
| Data Coordinating Center for the Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) Continuation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $8,663,508 | May 1, 2002 | June 30, 2028 | SHADE, DAVID M | reporter.nih.gov |
| The University of Kansas Cancer Center's- MCA Rural NCORP- extension | NIH | National Cancer Institute | 2021 to 2025 | $8,620,990 | August 13, 2019 | July 31, 2026 | DOOLITTLE, GARY C. | reporter.nih.gov |
| Glucagon-Like Peptide-1 Receptor Agonist Treatment in Adult, Obesity-Related, Symptomatic Asthma | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $8,604,388 | May 1, 2021 | April 30, 2027 | CAHILL, KATHERINE N | reporter.nih.gov |
| TCN PATHS Supplemental funding | NIH | National Institute on Drug Abuse | 2021 to 2024 | $8,572,442 | July 15, 2019 | April 30, 2026 | WANG, EMILY AI-HUA | reporter.nih.gov |
| Microbiome, Metabolites, and Alcohol in HIV to Reduce CVD (META HIV CVD) | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $8,561,222 | September 10, 2021 | August 31, 2026 | FREIBERG, MATTHEW S | reporter.nih.gov |
| Clinical and Translational Science Award | NIH | National Center for Advancing Translational Sciences | 2021 to 2022 | $8,548,346 | March 22, 2018 | April 30, 2023 | KELLER, MARLA J | reporter.nih.gov |
| MUSC Specialized Center of Research Excellence on Sex Differences Renewal 2022 | NIH | National Institute on Drug Abuse | 2021 to 2025 | $8,499,200 | September 1, 2002 | July 31, 2028 | MCRAE-CLARK, AIMEE L | reporter.nih.gov |
| Randomized Control Trial of oxygen therapy in Children and Adolescents with Down Syndrome and Obstructive Sleep Apnea | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $8,481,225 | September 1, 2022 | August 31, 2027 | AMIN, RAOUF S. | reporter.nih.gov |
| Use of a GLP-1 Agonist to Treat Opioid Use Disorder in Rats and Man | NIH | National Institute on Drug Abuse | 2024 to 2025 | $8,480,887 | September 30, 2019 | April 30, 2027 | GRIGSON, PATRICIA SUE | reporter.nih.gov |
| Hyperhydration to Improve Kidney Outcomes in Children with Shiga Toxin-Producing E. Coli Infection (HIKO STEC): A Multinational, Embedded, Cluster, Crossover, Randomized Trial | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $8,451,589 | September 17, 2021 | August 31, 2027 | FREEDMAN, STEPHEN BRADLEY | reporter.nih.gov |
| Atherosclerosis Intervention with Novel Tissue Selective Estrogen Complex Therapy | NIH | National Institute on Aging | 2021 to 2023 | $8,410,475 | March 1, 2019 | August 31, 2025 | HODIS, HOWARD NEIL | reporter.nih.gov |
| Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed with Crohn's Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $8,401,766 | April 1, 2023 | March 31, 2028 | HYAMS, JEFFREY SAMUEL | reporter.nih.gov |
| Rocky Mountain Cannabis Research Center | NIH | National Institute on Drug Abuse | 2023 to 2025 | $8,380,548 | September 1, 2023 | June 30, 2028 | HUTCHISON, KENT E. | reporter.nih.gov |
| San Francisco Bay Clinical Trials Unit (CTU) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $8,314,128 | March 2, 2007 | November 30, 2027 | BUCHBINDER, SUSAN | reporter.nih.gov |
| Yale-SCORE on Sex Differences in Alcohol Use Disorder | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $8,308,091 | March 10, 2020 | August 31, 2030 | MCKEE, SHERRY ANN | reporter.nih.gov |
| EPPIC-NET DCC - Supplement | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $8,306,997 | September 1, 2023 | August 31, 2025 | TROXEL, ANDREA B | reporter.nih.gov |
| Development of a monoclonal antibody to reverse overdose from fentanyl and its analogs: from manufacturing to clinical trials | NIH | National Institute on Drug Abuse | 2022 | $8,267,350 | September 30, 2022 | September 29, 2025 | PRAVETONI, MARCO | reporter.nih.gov |
| Back Pain Consortium (BACPAC) Research Program Data Integration, Algorithm Development and Operations Management Center | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $8,257,593 | September 26, 2019 | August 31, 2025 | ANSTROM, KEVIN J | reporter.nih.gov |
| Boston OAIC: A Translational Approach to Function Promoting Therapies | NIH | National Institute on Aging | 2021 to 2025 | $8,257,493 | September 1, 2008 | June 30, 2027 | BHASIN, SHALENDER | reporter.nih.gov |
| Development of a Long-acting Enzyme Therapy for Treatment of Cocaine Abuse | NIH | National Institute on Drug Abuse | 2021 to 2022 | $8,242,506 | August 15, 2020 | April 30, 2026 | ZHAN, CHANG-GUO | reporter.nih.gov |
| The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit. | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $8,239,326 | January 15, 2008 | November 30, 2027 | GRINSZTEJN, BEATRIZ | reporter.nih.gov |
| Tailored Non-Pharmacotherapy Services for Chronic Pain: Testing Scalable and Pragmatic Approaches - Admin Supplement | NIH | National Institute on Aging | 2021 to 2023 | $8,205,902 | September 30, 2019 | August 31, 2025 | DEBAR, LYNN L. | reporter.nih.gov |
| Center for American Indian and Rural Health Equity | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $8,200,764 | September 15, 2014 | August 31, 2025 | ADAMS, ALEXANDRA K. | reporter.nih.gov |
| A Multicenter Randomized Controlled Trial of Surveillance versus. Endoscopic Therapy for Barretts Esophagus with Low-grade Dysplasia: The SURVENT Trial | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $8,184,774 | May 15, 2022 | April 30, 2027 | WANI, SACHIN | reporter.nih.gov |
| Molecular Transducers of Physical Activity Consortium - Colorado Clinical Center | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $8,180,423 | December 6, 2016 | August 30, 2025 | KOHRT, WENDY M | reporter.nih.gov |
| Combining Pregabalin with Lofexidine: Can it Increase the Success of Transition to Naltrexone? | NIH | National Institute on Drug Abuse | 2023 to 2025 | $8,178,365 | September 30, 2019 | August 31, 2026 | KAMPMAN, KYLE MATTHEW | reporter.nih.gov |
| Emergency General Surgery Delirium Recovery Model: A Collaborative Care Intervention | NIH | National Institute on Aging | 2022 to 2025 | $8,173,947 | July 1, 2022 | June 30, 2027 | ZARZAUR, BEN L | reporter.nih.gov |
| Dartmouth Clinical and Translational Science Institute | NIH | National Center for Advancing Translational Sciences | 2024 to 2025 | $8,141,832 | July 25, 2024 | June 30, 2031 | BERNSTEIN, STEVEN L | reporter.nih.gov |
| Therapeutic Agent for Rapid Reversal of Methamphetamine Intoxication | NIH | National Institute on Drug Abuse | 2021 to 2022 | $8,123,947 | September 30, 2020 | May 31, 2024 | LI, XINHUA | reporter.nih.gov |
| Alzheimer's Prevention Initiative ADAD Colombia Trial | NIH | National Institute on Aging | 2021 to 2022 | $8,118,116 | April 1, 2017 | September 30, 2024 | REIMAN, ERIC MICHAEL | reporter.nih.gov |
| The Exercise and Physical Activity Collaborative Team (ExPACT): A MoTrPAC Clinical Center | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $8,095,970 | December 6, 2016 | August 30, 2025 | TRAPPE, SCOTT | reporter.nih.gov |
| The NCI Community Oncology Research Program: The New Mexico NCORP | NIH | National Cancer Institute | 2021 to 2025 | $8,085,672 | August 9, 2014 | July 31, 2026 | MULLER, CAROLYN Y. | reporter.nih.gov |
| CLINICAL STUDIES MANAGEMENT AND SUPPORT (CSMS) - SOLE SOURCE BRIDGE CONTRACT | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $8,078,483 | September 30, 2021 | January 24, 2025 | YOU, HUIQING | reporter.nih.gov |
| 1/2 Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients with Acute Respiratory Failure and Sepsis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $8,010,367 | September 16, 2020 | August 31, 2025 | BOECKH, MICHAEL J | reporter.nih.gov |
| Genomic risk in clinical care to promote preventive health in New York City patients | NIH | National Human Genome Research Institute | 2021 to 2025 | $7,984,720 | July 1, 2020 | April 30, 2027 | KENNY, EIMEAR ELIZABETH | reporter.nih.gov |
| CTSA UM1 Program at Wake Forest | NIH | National Center for Advancing Translational Sciences | 2024 to 2025 | $7,981,899 | July 1, 2024 | June 30, 2031 | HOUSTON, THOMAS K | reporter.nih.gov |
| Sex Differences in Major Depression: Impact of Prenatal Stress-Immune and Autonomic Dysregulation | NIH | National Institute of Mental Health | 2021 to 2024 | $7,968,668 | February 1, 2020 | April 24, 2025 | GOLDSTEIN, JILL M | reporter.nih.gov |
| Global Leukodystrophy Initiative Clinical Trials Network (GLIA- CTN) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $7,961,338 | September 30, 2019 | August 31, 2030 | VANDERVER, ADELINE LUCIE | reporter.nih.gov |
| THE NIH PRECISION BRAIN HEALTH NETWORK: Open and Inclusive Measurement of Neuropsychological Change for AD/ADRD Primary Prevention Trials | NIH | National Institute on Aging | 2025 | $7,948,867 | August 1, 2025 | July 31, 2030 | SLIWINSKI, MARTIN J | reporter.nih.gov |
| Using Implementation Interventions and Peer Recovery Support to Improve Opioid Treatment Outcomes in Community Supervision | NIH | National Institute on Drug Abuse | 2021 to 2024 | $7,947,350 | August 1, 2019 | April 30, 2025 | MARTIN, ROSEMARIE A | reporter.nih.gov |
| Development of SBS-226, a MOR agonist / DOR antagonist, for OUD | NIH | National Institute on Drug Abuse | 2024 to 2025 | $7,941,988 | September 30, 2024 | August 31, 2027 | REICH, JEFFREY | reporter.nih.gov |
| Phosphate binder therapy and chronic kidney disease in children | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,929,421 | June 15, 2020 | April 30, 2026 | SALUSKY, ISIDRO B. | reporter.nih.gov |
| SUPPORT SERVICES FOR THE CTEP PHARMACEUTICAL MANAGEMENT BRANCH (PMB) | NIH | National Cancer Institute | 2022 to 2025 | $7,922,356 | September 1, 2022 | August 31, 2026 | GRAY, ARIE | reporter.nih.gov |
| RACE-CARS CCC 1/2 | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $7,922,259 | July 1, 2020 | June 30, 2027 | GRANGER, CHRISTOPHER B. | reporter.nih.gov |
| Diabetes Research Center (DRC) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,913,084 | December 1, 2002 | June 30, 2028 | SALTIEL, ALAN R. | reporter.nih.gov |
| External Quality Assurance Program Oversight Laboratory (EQAPOL) | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $7,902,910 | September 30, 2024 | September 29, 2031 | DENNY, THOMAS | reporter.nih.gov |
| Communication Bridge: Optimizing an evidence-based intervention for individuals with primary progressive aphasia | NIH | National Institute on Aging | 2023 to 2025 | $7,878,167 | September 15, 2017 | August 31, 2028 | ROGALSKI, EMILY J | reporter.nih.gov |
| Development of the novel mu-opioid receptor antagonist methocinnamox (MCAM) for preventing relapse and overdose | NIH | National Institute on Drug Abuse | 2024 to 2025 | $7,874,666 | August 15, 2024 | December 31, 2027 | FRANCE, CHARLES P | reporter.nih.gov |
| The University of Iowa Clinical and Translational Science Award | NIH | National Center for Advancing Translational Sciences | 2021 to 2022 | $7,847,360 | March 30, 2018 | March 31, 2023 | WINOKUR, PATRICIA | reporter.nih.gov |
| NIAID CLINICAL DATA AND SAFETY MANAGEMENT CENTER (CDSMC) | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $7,818,967 | September 15, 2021 | September 14, 2022 | MOLINA, DANIEL | reporter.nih.gov |
| Columbia Diabetes Research Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,800,557 | September 1, 2002 | December 31, 2027 | PAJVANI, UTPAL | reporter.nih.gov |
| Greater Southern California Node of the Clinical Trials Network | NIH | National Institute on Drug Abuse | 2021 to 2025 | $7,788,993 | June 1, 2019 | February 29, 2032 | MOONEY, LARISSA JEANETTE | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| Johns Hopkins University | Baltimore, MD | 443 | $1.08 billion | 0 | $0 |
| University of California Los Angeles | Los Angeles, CA | 216 | $894 million | 0 | $0 |
| Fred Hutchinson Cancer Center | Seattle, WA | 70 | $858.9 million | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 389 | $794.2 million | 0 | $0 |
| Duke University | Durham, NC | 267 | $731.6 million | 0 | $0 |
| PPD Development LP | Wilmington, NC | 7 | $720 million | 0 | $0 |
| Yale University | New Haven, CT | 282 | $711.2 million | 0 | $0 |
| Massachusetts General Hospital | Boston, MA | 359 | $613.5 million | 0 | $0 |
| Columbia University Health Sciences | New York, NY | 200 | $554.5 million | 0 | $0 |
| Washington University | Saint Louis, MO | 193 | $535.1 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 283 | $514.2 million | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 278 | $491.7 million | 0 | $0 |
| New York University School of Medicine | New York, NY | 174 | $491.3 million | 0 | $0 |
| University of Pennsylvania | Philadelphia, PA | 277 | $485.1 million | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 125 | $476.9 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 188 | $472.6 million | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 255 | $470.8 million | 0 | $0 |
| Emory University | Atlanta, GA | 210 | $426.9 million | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 200 | $412.4 million | 0 | $0 |
| Northwestern University at Chicago | Chicago, IL | 202 | $398.9 million | 0 | $0 |
| University of Alabama at Birmingham | Birmingham, AL | 208 | $387 million | 0 | $0 |
| University of Washington | Seattle, WA | 270 | $381.7 million | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 234 | $363.7 million | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 166 | $359.7 million | 0 | $0 |
| Fred Hutchinson Cancer Research Center | Seattle, WA | 42 | $326.3 million | 0 | $0 |
| Stanford University | Stanford, CA | 199 | $318.7 million | 0 | $0 |
| University of Southern California | Los Angeles, CA | 97 | $297.2 million | 0 | $0 |
| University of Utah | Salt Lake City, UT | 152 | $293.7 million | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 157 | $277.9 million | 0 | $0 |
| Oregon Health & Science University | Portland, OR | 108 | $260.2 million | 0 | $0 |
| Ohio State University | Columbus, OH | 138 | $259.5 million | 0 | $0 |
| Mayo Clinic Rochester | Rochester, MN | 130 | $250.4 million | 0 | $0 |
| University of Chicago | Chicago, IL | 97 | $248.4 million | 0 | $0 |
| Scripps Research Institute, the | La Jolla, CA | 8 | $244 million | 0 | $0 |
| Weill Medical Coll of Cornell Univ | New York, NY | 106 | $240.2 million | 0 | $0 |
| Wake Forest University Health Sciences | Winston-Salem, NC | 99 | $238.6 million | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 114 | $228.9 million | 0 | $0 |
| Medical University of South Carolina | Charleston, SC | 131 | $226.4 million | 0 | $0 |
| Family Health International | Durham, NC | 3 | $217.5 million | 0 | $0 |
| University of Wisconsin-Madison | Madison, WI | 120 | $213.1 million | 0 | $0 |
| Case Western Reserve University | Cleveland, OH | 86 | $211 million | 0 | $0 |
| Ut Southwestern Medical Center | Dallas, TX | 85 | $210.8 million | 0 | $0 |
| University of TX MD Anderson Can CTR | Houston, TX | 88 | $206.3 million | 0 | $0 |
| Benaroya Research Inst at Virginia Mason | Seattle, WA | 2 | $204.2 million | 0 | $0 |
| Westat, Inc. | Bethesda, MD | 6 | $201.6 million | 0 | $0 |
| Harvard University D/b/a Harvard School of Public Health | Boston, MA | 34 | $201.4 million | 0 | $0 |
| University of Florida | Gainesville, FL | 118 | $193.2 million | 0 | $0 |
| Cincinnati Childrens Hosp Med CTR | Cincinnati, OH | 86 | $188.6 million | 0 | $0 |
| University of Kentucky | Lexington, KY | 105 | $186.2 million | 0 | $0 |
| Kaiser Foundation Research Institute | Oakland, CA | 80 | $186.1 million | 0 | $0 |
| University of South Florida | Tampa, FL | 31 | $179.4 million | 0 | $0 |
| University of Rochester | Rochester, NY | 110 | $178.5 million | 0 | $0 |
| Research Triangle Institute | Research Triangle Park, NC | 45 | $178.2 million | 0 | $0 |
| University of Kansas Medical Center | Kansas City, KS | 82 | $176.9 million | 0 | $0 |
| University of Maryland Baltimore | Baltimore, MD | 80 | $174.7 million | 0 | $0 |
| Public Health Institute | Oakland, CA | 3 | $169 million | 0 | $0 |
| University of Texas HLTH Sci CTR Houston | Houston, TX | 93 | $166.1 million | 0 | $0 |
| Baylor College of Medicine | Houston, TX | 84 | $163.3 million | 0 | $0 |
| University of Arizona | Tucson, AZ | 59 | $162.2 million | 0 | $0 |
| Brown University | Providence, RI | 105 | $158.4 million | 0 | $0 |
| University of Virginia | Charlottesville, VA | 82 | $153 million | 0 | $0 |
| University of Miami School of Medicine | Coral Gables, FL | 62 | $149.8 million | 0 | $0 |
| Dana-Farber Cancer Inst | Boston, MA | 60 | $148.3 million | 0 | $0 |
| University of Illinois at Chicago | Chicago, IL | 111 | $145.4 million | 0 | $0 |
| Medical College of Wisconsin | Milwaukee, WI | 65 | $129.9 million | 0 | $0 |
| Children's Hosp of Philadelphia | Philadelphia, PA | 90 | $129.1 million | 0 | $0 |
| George Washington University | Washington, DC | 46 | $128.9 million | 0 | $0 |
| Univ of Arkansas for Med Scis | Little Rock, AR | 27 | $127.8 million | 0 | $0 |
| Sloan-Kettering Inst Can Research | New York, NY | 82 | $126 million | 0 | $0 |
| Albert Einstein College of Medicine | Bronx, NY | 63 | $125.6 million | 0 | $0 |
| Univ of Massachusetts Med SCH Worcester | Worcester, MA | 64 | $119.8 million | 0 | $0 |
| Northern California Institute/res/edu | San Francisco, CA | 13 | $118.1 million | 0 | $0 |
| University of Iowa | Iowa City, IA | 69 | $117.3 million | 0 | $0 |
| Seattle Children's Hospital | Seattle, WA | 62 | $115.7 million | 0 | $0 |
| University of California at Davis | Davis, CA | 67 | $109.7 million | 0 | $0 |
| Beth Israel Deaconess Medical Center | Boston, MA | 62 | $104.7 million | 0 | $0 |
| Boston Children's Hospital | Boston, MA | 59 | $104.3 million | 0 | $0 |
| Beckman Research Institute/city of Hope | Duarte, CA | 44 | $104.1 million | 0 | $0 |
| Technical Resources International, Inc. | Bethesda, MD | 6 | $101.3 million | 0 | $0 |
| Pennsylvania State Univ Hershey Med CTR | Hershey, PA | 51 | $99 million | 0 | $0 |
| Ecog-Acrin Medical Research Foundation | Philadelphia, PA | 2 | $98.2 million | 0 | $0 |
| University of California-Irvine | Irvine, CA | 54 | $95.8 million | 0 | $0 |
| Cedars-Sinai Medical Center | Los Angeles, CA | 47 | $92.6 million | 0 | $0 |
| Cleveland Clinic Lerner Com-Cwru | Cleveland, OH | 55 | $91.5 million | 0 | $0 |
| Ctis, Inc. | Rockville, MD | 1 | $86.9 million | 0 | $0 |
| Cognition Therapeutics, Inc. | Pittsburgh, PA | 5 | $86.6 million | 0 | $0 |
| Tufts University Boston | Boston, MA | 18 | $85.2 million | 0 | $0 |
| Jaeb Center for Health Research, Inc. | Tampa, FL | 5 | $84.6 million | 0 | $0 |
| Boston Medical Center | Boston, MA | 52 | $83 million | 0 | $0 |
| Rutgers Biomedical and Health Sciences | Newark, NJ | 66 | $81.4 million | 0 | $0 |
| University of Cincinnati | Cincinnati, OH | 44 | $81.2 million | 0 | $0 |
| New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, INC | New York, NY | 57 | $80.4 million | 0 | $0 |
| New York University | New York, NY | 59 | $80.3 million | 0 | $0 |
| Dartmouth College | Hanover, NH | 19 | $77.7 million | 0 | $0 |
| Florida State University | Tallahassee, FL | 33 | $77.4 million | 0 | $0 |
| University of Texas HLTH Science Center | San Antonio, TX | 39 | $77.1 million | 0 | $0 |
| University of Texas at Austin | Austin, TX | 59 | $74.7 million | 0 | $0 |
| ST. Jude Children's Research Hospital | Memphis, TN | 25 | $73.6 million | 0 | $0 |
| University of Oklahoma HLTH Sciences CTR | Oklahoma City, OK | 46 | $71 million | 0 | $0 |
| Virginia Commonwealth University | Richmond, VA | 62 | $67.9 million | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 7,240 | $6,567,970,973 | 0 | $0 |
| 2024 | 7,708 | $6,483,815,353 | 0 | $0 |
| 2023 | 7,730 | $6,677,887,891 | 0 | $0 |
| 2022 | 7,495 | $6,684,398,305 | 0 | $0 |
| 2021 | 6,981 | $6,865,042,430 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.